propranolol has been researched along with Tremor in 267 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol, a nonselective beta-adrenergic blocker, has long been used as one of the standard treatments for essential tremor (ET)." | 9.69 | Cerebellar repetitive transcranial magnetic stimulation versus propranolol for essential tremor. ( Cheng, J; Du, D; Li, H; Lv, Y; Shi, J; Wang, M; Xuan, T; Yang, J; Zhang, J, 2023) |
| "Botulinum toxin produced statistically significant improvements in perceptual measures of vocal instability in patients with dystonic vocal tremors compared with baseline values and treatment with propranolol." | 9.27 | Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors. ( Biase, NG; Guglielmino, G; Moraes, BT; Padovani, M; Villanova, LC, 2018) |
| "To study the effects of gabapentin in a comparative, double-blind, crossover, placebo-controlled trial of patients who have essential tremor." | 9.09 | A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. ( Barbanoj, M; Gironell, A; Hernández, G; Kulisevsky, J; López-Villegas, D; Pascual-Sedano, B, 1999) |
| "Propranolol, which has long been used as the standard treatment for essential tremor, has been compared with placebo and theophylline in ten newly diagnosed patients without other, prior drug treatments." | 9.08 | Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol. ( Mally, J; Stone, TW, 1995) |
| "To quantitatively measure the effects of caffeine and propranolol, a nonselective beta-blocking agent, on surgeon hand tremor during simulated vitreoretinal microsurgery." | 9.08 | Quantitative measurement of the effects of caffeine and propranolol on surgeon hand tremor. ( Awh, CC; de Juan, E; Humayun, MU; Pieramici, DJ; Rader, RS, 1997) |
| "We evaluated the use of propranolol as an adjunct to carbimazole in the treatment of hyperthyroid tremor and tachycardia in a double-blind, cross-over and placebo-controlled study." | 9.08 | Propranolol as an adjunct therapy for hyperthyroid tremor. ( Ghika, JA; Haller, E; Henderson, JM; Portmann, L; Van Melle, G, 1997) |
| "The effect of the beta-adrenoceptor antagonist propranolol has been investigated in nine patients suffering from isolated (six patients) or prominent (three patients) essential tremor of the head." | 9.07 | Effect of propranolol in head tremor: quantitative study following single-dose and sustained drug administration. ( Baratti, M; Calzetti, S; Fava, R; Negrotti, A; Sasso, E, 1992) |
| "Propranolol having been used for decades was compared with low dose theophylline and placebo in the treatment of essential tremor." | 9.07 | [Comparative study of theophylline and propranolol in essential tremor]. ( Málly, J, 1992) |
| "The chronic administration of theophylline was studied in twenty patients with essential tremor in a double-blind cross-over trial." | 9.07 | The effect of theophylline on essential tremor: the possible role of GABA. ( Mally, J; Stone, TW, 1991) |
| "Accelerometric tremorgrams were recorded from 25 subjects affected by essential tremor and analysed by a Berg-Fourier frequency analyser before and during venous infusion of the following drugs: propranolol (beta-blocker), clonidine (alpha-presynaptic adrenergic agonist), urapidil (alpha-postsynaptic blocker), trazodone (adrenolytic agent) and placebo." | 9.06 | Propranolol, clonidine, urapidil and trazodone infusion in essential tremor: a double-blind crossover trial. ( Caccia, MR; Cataldi, G; Galimberti, V; Mangoni, A; Osio, M, 1989) |
| "Primidone was compared to the unselective beta adrenoceptor antagonist propranolol in the suppression of essential tremor." | 9.06 | Primidone and propranolol in essential tremor: a study based on quantitative tremor recording and plasma anticonvulsant levels. ( Dietrichson, P; Espen, E, 1987) |
| " The effects of the selective beta 2-adrenoceptor antagonist ICI 118551 on essential tremor, heart rate and blood pressure were compared with those of propranolol." | 9.06 | The comparative effects of ICI 118551 and propranolol on essential tremor. ( Birmingham, AT; Jefferson, D; Patrick, JM; Wharrad, HJ, 1987) |
| "In a double blind, comparative study with 15 patients, a long-acting formulation of propranolol taken once daily (at doses of 160, 240 and 320 mg), was shown to be as effective as conventional propranolol (80 mg three times daily) in reducing the amplitude of essential tremor." | 9.06 | Propranolol and propranolol-LA in essential tremor: a double blind comparative study. ( Cleeves, L; Findley, LJ, 1988) |
| "The effects of placebo, propranolol and primidone were compared in 14 patients with essential tremor in a double blind, randomised, crossover study." | 9.06 | A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. ( Campbell, MJ; Cooper, R; Gorman, WP; Pocock, P, 1986) |
| "Primidone, 50 to 1,000 mg/d, reduced the amplitude of essential tremor in both untreated and propranolol-treated patients." | 9.06 | Efficacy of primidone in essential tremor. ( Koller, WC; Royse, VL, 1986) |
| "The factors influencing the response of essential tremor to prolonged administration of propranolol (120 mg daily for two weeks followed by 240 mg daily for a further two weeks) were investigated in a double-blind, cross-over, placebo-controlled study in 16 patients." | 9.05 | The response of essential tremor to propranolol: evaluation of clinical variables governing its efficacy on prolonged administration. ( Calzetti, S; Findley, LJ; Perucca, E; Richens, A, 1983) |
| " Log dose-response curves for increases in both heart rate (mostly beta 1), and amplitude of physiologic tremor (beta 2) were constructed for each subject in the control state and 2 hr after 10 or 40 mg propranolol, 200 mg sotalol, or placebo." | 9.05 | Propranolol and sotalol as antagonists of isoproterenol-enhanced physiologic tremor. ( Fish, A; Perucca, E; Pickles, H; Richens, A, 1981) |
| "The effect of single oral doses of atenolol (100 mg), metoprolol (100 mg), propranolol (40 mg), and placebo on exercise tachycardia and on heart rate and finger tremor responses to graded injections of isoproterenol was investigated in six normal subjects." | 9.05 | Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects. ( Perucca, E; Pickles, H; Richens, A, 1981) |
| "The effect of a single oral dose of propranolol (120 mg) on essential tremor was investigated in a double-blind, placebo-controlled study in 26 patients." | 9.05 | Effect of a single oral dose of propranolol on essential tremor: a double-blind controlled study. ( Calzetti, S; Findley, LJ; Gresty, MA; Perucca, E; Richens, A, 1983) |
| "The effect of propranolol on essential tremor affecting the head was studied in a placebo-controlled trial." | 9.05 | Propranolol therapy for essential tremor of the head. ( Koller, WC, 1984) |
| "The effect of the withdrawal of long-term beta-adrenoceptor blockade on pulse rate and finger tremor was studied in 27 patients who had been treated for 2 years following an uncomplicated myocardial infarction with either atenolol, propranolol or placebo." | 9.05 | Effect on finger tremor of withdrawal of long-term treatment with propranolol or atenolol. ( Birmingham, AT; Roland, JM; Wharrad, HJ; Williams, EJ; Wilson, CG, 1984) |
| "The efficacy of propranolol and metoprolol in the treatment of essential tremor was compared in a double blind crossover placebo-controlled study in 16 patients." | 9.05 | Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor. ( Calzetti, S; Findley, LJ; Perucca, E; Richens, A, 1982) |
| "Single oral doses of propranolol (120 mg), metoprolol (150 mg) and placebo were given in a randomised, double-blind fashion to 23 patients with essential tremor." | 9.05 | Metoprolol and propranolol in essential tremor: a double-blind, controlled study. ( Calzetti, S; Findley, LJ; Gresty, MA; Perucca, E; Richens, A, 1981) |
| "We studied chronic oral propranolol therapy and placebo in seven patients with essential voice tremor." | 9.05 | Essential voice tremor: treatment with propranolol. ( Graner, D; Koller, W; Mlcoch, A, 1985) |
| "The effects of 120 mg propranolol and 15 mg pindolol daily on positional tremor of 24 patients with benign essential tremor were analyzed with a double-blind crossover trial and electrical tremor recording." | 9.04 | Comparison between the effects of pindolol and propranolol on essential tremor. ( Fogelholm, R; Larsen, A; Teravainen, H, 1977) |
| "The effect of the beta-adrenergic blocking agent propranolol was tested on positional tremor occurring during acute alcohol withdrawal using a double-blind crossover method and electrical recording of tremor amplitude and frequency." | 9.04 | Effect of propranolol on acute withdrawal tremor in alcoholic patients. ( Larsen, A; Teräväinen, H, 1976) |
| "In a double-blind crossover study 12 patients with essential tremor were treated with propranolol and a placebo; 8 improved with propranolol and 3 with the placebo; the degree of improvement with propranolol was greater." | 9.04 | Long-term therapy of essential tremor with propranolol. ( Murray, TJ, 1976) |
| "Practolol, propranolol, and placebo have been tested on an objective test of lithium induced tremor." | 9.04 | Beta blockade in lithium tremor. ( Bailey, J; Coppen, AJ; Kellett, JM; Metcalfe, M, 1975) |
| "The investigators tested the effect of 120 mg propranolol daily on 21 patients with essential tremor using a double-blind cross-over method and electrical recording of tremor amplitude and frequency." | 9.04 | Effect of propranolol on essential tremor. ( Fogelholm, R; Larsen, A; Teräväinen, H, 1976) |
| "A double-blind trial of propranolol, in a dosage of 120 mg a day, and placebo was conducted in 11 patients with essential tremor." | 9.04 | Essential tremor: treatment with propranolol. ( Loewenson, RB; Tolosa, ES, 1975) |
| "A double blind trial of a single 40 mg dose of the beta adrenergic blocking agent propranolol in the treatment of essential tremor produced significant reduction of tremor in four of five patients, but this effect was transient and had considerably diminished within four hours." | 9.04 | Effect of the beta adrenergic blocking agent propranolol on essential tremor. ( Cooper, R; Hewer, RL; Morgan, MH, 1973) |
| "Harmaline-induced tremor in rodents is a model of essential tremor." | 7.75 | Pharmacological characterization of harmaline-induced tremor activity in mice. ( Foreman, MM; Hanania, T; Malekiani, SA; Olivier, B; Paterson, NE, 2009) |
| "The effects of nicotinic and beta-adrenergic receptor antagonists on tail-tremor induced by repeated nicotine administration were investigated in rats." | 7.69 | Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. ( Gomita, Y; Kawasaki, H; Oishi, R; Suemaru, K; Tanizaki, Y, 1997) |
| "The repeated administration of nicotine at small doses, which do not produce whole body tremor or convulsion, causes tremor only in the tail (tail-tremor) of rats." | 7.69 | [Assessment of anti-tremorogenic drugs--nicotine-induced tail-tremor model]. ( Gomita, Y; Kawasaki, H; Suemaru, K, 1997) |
| "The cases of two asthmatic adolescents who overdosed on albuterol are presented." | 7.68 | Propranolol treatment of albuterol poisoning in two asthmatic patients. ( Henretig, F; Joffe, M; Ramoska, EA; Spiller, HA, 1993) |
| "The effect of arotinolol, a peripherally acting beta-adrenergic-blocking agent, on postural or kinetic tremor was studied in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism." | 7.68 | Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys. ( Kuno, S; Mizuta, E; Nishida, J; Takechi, M, 1992) |
| "We treated 28 patients (16 women and 12 men) who had essential tremor with methazolamide." | 7.68 | Treatment of essential tremor with methazolamide. ( Caviness, JN; Daube, JR; Miller, PM; Muenter, MD, 1991) |
| "Despite a large number of studies demonstrating the effectiveness of propranolol in relieving essential tremor (ET) the long-term therapeutic outcome of these patients remains poorly defined." | 7.68 | Clinical and computer-based assessment of long-term therapeutic efficacy of propranolol in essential tremor. ( Baratti, M; Calzetti, S; Fava, R; Sasso, E, 1990) |
| "Non-selective adrenergic beta-blocking drugs prevented isoproterenol enhancement of essential tremor amplitude far more effectively than beta-1-selective blockers." | 7.67 | Beta-blockers in isoproterenol-enhanced essential tremor. ( Teräväinen, H, 1984) |
| "We analyzed effects of metoprolol tartrate and propranolol hydrochloride on 23 patients with essential tremor." | 7.67 | Metoprolol compared with propranolol in the treatment of essential tremor. ( Biary, N; Koller, WC, 1984) |
| "We studied the acute and chronic effects of propranolol and primidone in essential tremor by administering long-acting propranolol (80 to 160 mg/d) and primidone (50 to 250 mg/d) to 50 patients." | 7.67 | Acute and chronic effects of propranolol and primidone in essential tremor. ( Koller, WC; Vetere-Overfield, B, 1989) |
| "Propranolol in low doses antagonized and in higher doses facilitated oxotremorine-induced tremor (Oxo-tremor) in mice." | 7.67 | Cholinergic involvement in the modulation of oxotremorine-tremor in mice by propranolol. ( Alkondon, M; Ray, A; Sen, P, 1985) |
| "The tremorogenic effect of nicotine was studied in control rats and in rats withdrawn for 16-48 h from six to nine days' ethanol administration." | 7.67 | Ethanol withdrawal tremor potentiates the tremorogenic action of nicotine. ( Gothóni, P; Ikola, W, 1985) |
| "Tremor induced by TRH and oxotremorine was recorded by a capacitance transducer, and its intensity and frequency were evaluated using power arrays." | 7.67 | [Power spectral analysis of tremor induced by TRH and oxotremorine in mice]. ( Fukuda, T; Izumi, K; Koja, T; Nomoto, M; Shimizu, T, 1986) |
| "An 80-year-old man who had had plaque-type psoriasis for 40 years experienced a rapid onset of generalized pustular psoriasis three days after initiation of propranolol hydrochloride therapy." | 7.67 | Generalized pustular psoriasis provoked by propranolol. ( Farber, EM; Hu, CH; Miller, AC; Peppercorn, R, 1985) |
| "The effect of doses of propranolol hydrochloride, 80 to 800 mg/day, was investigated in 15 patients with essential tremor." | 7.67 | Dose-response relationship of propranolol in the treatment of essential tremor. ( Koller, WC, 1986) |
| "Long-acting propranolol (propranolol-LA) was compared with propranolol in divided doses in 18 patients with essential tremor." | 7.67 | Long-acting propranolol in essential tremor. ( Koller, WC, 1985) |
| "We studied the effects of a single oral dose (120 mg) of propranolol on essential tremor in 12 patients." | 7.67 | Time course of a single oral dose of propranolol in essential tremor. ( Koller, WC; Royse, VL, 1985) |
| "The tremorogenic effect of nicotine was studied in control rats and in rats withdrawn for 16-48 h from chronic ethanol administration." | 7.66 | Hypersensitivity to the tremorogenic action of nicotine in rats withdrawn from ethanol. ( Gothóni, P, 1983) |
| "Primidone given to a patient for epilepsy produced an unexpected reduction in benign familial tremor." | 7.66 | Benign familial tremor treated with primidone. ( O'Brien, MD; Toseland, PA; Upton, AR, 1981) |
| "Assessment of an elderly depressed patient with an imipramine-induced tremor led to the conclusions that imipramine tremor (1) can be severe and incapacitating, (2) is most pronounced early in the treatment, (3) does not seem to be dose-related, and (4) is readily reversible with a beta-adrenergic blocking agent." | 7.66 | Imipramine-induced tremor: effects of a beta-adrenergic blocking agent. ( Greden, JF; Kronfol, Z; Zis, AP, 1983) |
| "The beta-1 selective, hydrophilic adrenoceptor blocking drug atenolol (100 mg daily) was compared to the non-selective, lipid-soluble beta-blocker propranolol (240 mg daily), and to placebo, in a double-blind cross-over study in 24 patients with essential tremor." | 7.66 | Atenolol vs. propranolol in essential tremor. A controlled, quantitative study. ( Calne, DB; Larsen, TA; Teräväinen, H, 1982) |
| "Five patients with essential tremor were treated with increasing daily doses of propranolol." | 7.66 | Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels. ( Jansen, EC; Paulson, OB; Steiness, E; Sørensen, PS, 1981) |
| "The role of peripheral catecholamines in mediating the pressor and tremorigenic effects of oxotremorine were investigated in conscious rats." | 7.66 | Peripheral catecholamines mediate certain responses to central cholinergic receptor stimulation by oxotremorine. ( Kopin, IJ; Weinstock, M; Zavadil, AP, 1980) |
| "The relationship between plasma propranolol concentration and relief of essential tremor was examined in 11 patients during treatment with oral racemic propranolol in doses of 30 to 640 mg/day." | 7.66 | Relationship between plasma propranolol concentration and relief of essential tremor. ( Jefferson, D; Jenner, P; Marsden, CD, 1979) |
| "In addition to the various possibilities of influencing lithium tremor, experience gathered from the application of beta-receptor blockers is reported, and concepts investigated on the potential genesis and working mechanisms." | 7.65 | [Lithium tremor-combination treatment with beta receptor blockaders]. ( König, L, 1975) |
| " The effect of various agents injected into the cerebral ventricles of the mouse, upon the tremor and hypothermia produced by oxotremorine (0." | 7.65 | Modification of oxotremorine tremor and hypothermia by injections of drugs into the cerebral ventricles of the mouse. ( Doggett, NS; O'Farrell, SA, 1976) |
| " The influence of propranolol on the neuromuscular, tremor-producing and muscarinic effects of oxotremorine was examined." | 7.65 | Antioxotremorine action of propranolol. ( Ganguly, DK, 1976) |
| "Lithium tremor is an irregular, nonrhythmic tremor of the distal extremities, variable in both intensity and frequency." | 7.65 | Control of lithium tremor with propranolol. ( Lapierre, YD, 1976) |
| " In rats the effect of drugs on oxotremorine tremor and oxotremorine-induced increase in brain acetylcholine has been investigated." | 7.65 | Effects of drugs on tremor and increase in brain acetylcholine produced by oxotremorine in the rat. ( Cox, B; Potkonjak, D, 1970) |
| "While caffeine and propranolol were associated with performance changes among novices, only tremor was affected in seniors, without dexterity changes." | 5.69 | Weight-adjusted caffeine and β-blocker use in novice versus senior retina surgeons: a self-controlled study of simulated performance. ( Belfort Junior, R; Caiado, R; da Cruz Noia, L; da Silveira Saraiva, V; Eid Farah, M; Fernandes, RAB; Gehlbach, PL; Jiramongkolchai, K; Magalhães Junior, O; Maia, M; Nakanami, MH; Passos, RM; Roizenblatt, M; Stefanini, FR; Watanabe, SES; Wolf, M; Yasaki, ES, 2023) |
| "Propranolol, a nonselective beta-adrenergic blocker, has long been used as one of the standard treatments for essential tremor (ET)." | 5.69 | Cerebellar repetitive transcranial magnetic stimulation versus propranolol for essential tremor. ( Cheng, J; Du, D; Li, H; Lv, Y; Shi, J; Wang, M; Xuan, T; Yang, J; Zhang, J, 2023) |
| "Botulinum toxin produced statistically significant improvements in perceptual measures of vocal instability in patients with dystonic vocal tremors compared with baseline values and treatment with propranolol." | 5.27 | Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors. ( Biase, NG; Guglielmino, G; Moraes, BT; Padovani, M; Villanova, LC, 2018) |
| "Tremor was quantified 8 hr later by spectral analysis of whole body movements." | 5.27 | Modulation of p,p'-DDT-induced tremor by catecholaminergic agents. ( Herr, DW; Tilson, HA, 1987) |
| "To study the effects of gabapentin in a comparative, double-blind, crossover, placebo-controlled trial of patients who have essential tremor." | 5.09 | A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. ( Barbanoj, M; Gironell, A; Hernández, G; Kulisevsky, J; López-Villegas, D; Pascual-Sedano, B, 1999) |
| "Propranolol, which has long been used as the standard treatment for essential tremor, has been compared with placebo and theophylline in ten newly diagnosed patients without other, prior drug treatments." | 5.08 | Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol. ( Mally, J; Stone, TW, 1995) |
| "At rest salmeterol and formoterol exhibited equivalent beta 2 agonist activity with regard to decrease in serum potassium levels and increase in finger tremor, with propranolol having no effect." | 5.08 | Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol. ( Grove, A; Lipworth, BJ, 1996) |
| "To quantitatively measure the effects of caffeine and propranolol, a nonselective beta-blocking agent, on surgeon hand tremor during simulated vitreoretinal microsurgery." | 5.08 | Quantitative measurement of the effects of caffeine and propranolol on surgeon hand tremor. ( Awh, CC; de Juan, E; Humayun, MU; Pieramici, DJ; Rader, RS, 1997) |
| "We evaluated the use of propranolol as an adjunct to carbimazole in the treatment of hyperthyroid tremor and tachycardia in a double-blind, cross-over and placebo-controlled study." | 5.08 | Propranolol as an adjunct therapy for hyperthyroid tremor. ( Ghika, JA; Haller, E; Henderson, JM; Portmann, L; Van Melle, G, 1997) |
| "To determine whether propranolol can decrease surgical tremor and anxiety in residents performing ocular microsurgery without impairing patient or physician safety." | 5.08 | The effect of propranolol versus placebo on resident surgical performance. ( Anderson, RJ; Deutsch, TA; Elman, MJ; Fiscella, R; Noth, J; Nyberg, M; Packo, K; Sugar, J, 1998) |
| "To evaluate effect of the calcium-channel blocker nicardipine in essential tremor (ET), 14 patients with ET affecting upper limbs underwent a cross-over study with nicardipine (1 mg/Kg/day) and propranolol (160 mg/day)." | 5.07 | Nicardipine versus propranolol in essential tumor. ( Cabrera-Valdivia, F; Garcia-Ruiz, PJ; Jiménez-Jiménez, FJ, 1994) |
| "The effect of the beta-adrenoceptor antagonist propranolol has been investigated in nine patients suffering from isolated (six patients) or prominent (three patients) essential tremor of the head." | 5.07 | Effect of propranolol in head tremor: quantitative study following single-dose and sustained drug administration. ( Baratti, M; Calzetti, S; Fava, R; Negrotti, A; Sasso, E, 1992) |
| "Propranolol having been used for decades was compared with low dose theophylline and placebo in the treatment of essential tremor." | 5.07 | [Comparative study of theophylline and propranolol in essential tremor]. ( Málly, J, 1992) |
| "The chronic administration of theophylline was studied in twenty patients with essential tremor in a double-blind cross-over trial." | 5.07 | The effect of theophylline on essential tremor: the possible role of GABA. ( Mally, J; Stone, TW, 1991) |
| "Accelerometric tremorgrams were recorded from 25 subjects affected by essential tremor and analysed by a Berg-Fourier frequency analyser before and during venous infusion of the following drugs: propranolol (beta-blocker), clonidine (alpha-presynaptic adrenergic agonist), urapidil (alpha-postsynaptic blocker), trazodone (adrenolytic agent) and placebo." | 5.06 | Propranolol, clonidine, urapidil and trazodone infusion in essential tremor: a double-blind crossover trial. ( Caccia, MR; Cataldi, G; Galimberti, V; Mangoni, A; Osio, M, 1989) |
| "The effects of intravenous doses of propranolol, sotalol, timolol, atenolol and placebo on exercise-induced tachycardia and exercise-induced increases in hand tremor were assessed in four healthy volunteers." | 5.06 | Exercise-induced hand tremor: a possible test for beta 2-adrenoceptor selectivity in man? ( Abila, B; Marshall, RW; Richens, A; Wilson, JF, 1986) |
| "Eighteen patients with essential tremor were treated for 2 days with a non-selective adrenergic beta-blocking drug (dl-propranolol, 80 mg X 3), a beta-2-selective blocker (ICI-118." | 5.06 | Selective adrenergic beta-2-receptor blocking drug, ICI-118.551, is effective in essential tremor. ( Huttunen, J; Larsen, TA; Teräväinen, H, 1986) |
| "Primidone was compared to the unselective beta adrenoceptor antagonist propranolol in the suppression of essential tremor." | 5.06 | Primidone and propranolol in essential tremor: a study based on quantitative tremor recording and plasma anticonvulsant levels. ( Dietrichson, P; Espen, E, 1987) |
| " The effects of the selective beta 2-adrenoceptor antagonist ICI 118551 on essential tremor, heart rate and blood pressure were compared with those of propranolol." | 5.06 | The comparative effects of ICI 118551 and propranolol on essential tremor. ( Birmingham, AT; Jefferson, D; Patrick, JM; Wharrad, HJ, 1987) |
| "In a double blind, comparative study with 15 patients, a long-acting formulation of propranolol taken once daily (at doses of 160, 240 and 320 mg), was shown to be as effective as conventional propranolol (80 mg three times daily) in reducing the amplitude of essential tremor." | 5.06 | Propranolol and propranolol-LA in essential tremor: a double blind comparative study. ( Cleeves, L; Findley, LJ, 1988) |
| "551, 150 mg/day, prevented almost as effectively as the nonselective antagonist propranolol, 240 mg/day, the isoprenaline enhancement of essential tremor amplitude." | 5.06 | Adrenergic beta 2-selective blocker in isoprenaline-enhanced essential tremor. ( Huttunen, J; Teräväinen, H, 1987) |
| "The effects of placebo, propranolol and primidone were compared in 14 patients with essential tremor in a double blind, randomised, crossover study." | 5.06 | A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. ( Campbell, MJ; Cooper, R; Gorman, WP; Pocock, P, 1986) |
| "The effect of long-acting propranolol hydrochloride (160 mg/d), primidone (250 mg at night), and clonazepam (4 mg/d) on the resting, postural, and kinetic component of tremor was investigated in ten parkinsonian patients in a double-blind crossover design." | 5.06 | Adjuvant therapy of parkinsonian tremor. ( Herbster, G; Koller, WC, 1987) |
| "Acute effects of two calcium blockers, nifedipine and verapamil, were investigated on the tremor activity of 8 patients with essential tremor and compared with those of propranolol and placebo." | 5.06 | Calcium channel blockers and essential tremor. ( Dalkara, T; Onur, R; Topaktas, S, 1987) |
| "Primidone, 50 to 1,000 mg/d, reduced the amplitude of essential tremor in both untreated and propranolol-treated patients." | 5.06 | Efficacy of primidone in essential tremor. ( Koller, WC; Royse, VL, 1986) |
| "The factors influencing the response of essential tremor to prolonged administration of propranolol (120 mg daily for two weeks followed by 240 mg daily for a further two weeks) were investigated in a double-blind, cross-over, placebo-controlled study in 16 patients." | 5.05 | The response of essential tremor to propranolol: evaluation of clinical variables governing its efficacy on prolonged administration. ( Calzetti, S; Findley, LJ; Perucca, E; Richens, A, 1983) |
| " Log dose-response curves for increases in both heart rate (mostly beta 1), and amplitude of physiologic tremor (beta 2) were constructed for each subject in the control state and 2 hr after 10 or 40 mg propranolol, 200 mg sotalol, or placebo." | 5.05 | Propranolol and sotalol as antagonists of isoproterenol-enhanced physiologic tremor. ( Fish, A; Perucca, E; Pickles, H; Richens, A, 1981) |
| "In order to study the mode of action of beta-adrenoreceptor antagonists in essential tremor the efficacy of single oral doses of 2, 4 and 10 mg LI 32-468, a peripherally acting, selective beta-2 adrenoreceptor antagonist, was compared with a single oral dose of 120 mg propranolol in a randomised, double blind, placebo controlled trial." | 5.05 | Beta-adrenoreceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2 selective adrenoreceptor antagonist. ( Cleeves, L; Findley, LJ, 1984) |
| "The effect of single oral doses of atenolol (100 mg), metoprolol (100 mg), propranolol (40 mg), and placebo on exercise tachycardia and on heart rate and finger tremor responses to graded injections of isoproterenol was investigated in six normal subjects." | 5.05 | Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects. ( Perucca, E; Pickles, H; Richens, A, 1981) |
| "The effect of a single oral dose of propranolol (120 mg) on essential tremor was investigated in a double-blind, placebo-controlled study in 26 patients." | 5.05 | Effect of a single oral dose of propranolol on essential tremor: a double-blind controlled study. ( Calzetti, S; Findley, LJ; Gresty, MA; Perucca, E; Richens, A, 1983) |
| "The beta 1-selective blocker metoprolol was compared to propranolol and a placebo in a double-blind crossover trial in 24 patients with essential tremor." | 5.05 | Beta 1 versus nonselective blockade in therapy of essential tremor. ( Larsen, TA; Teräväinen, H, 1983) |
| "We studied the effect of long-term administration of propranolol hydrochloride and isoniazid and the acute action of ethyl alcohol on cerebellar tremor in patients with multiple sclerosis and primary cerebellar degeneration in a placebo-controlled double-blind crossover test." | 5.05 | Pharmacologic trials in the treatment of cerebellar tremor. ( Koller, WC, 1984) |
| "The effect of propranolol on essential tremor affecting the head was studied in a placebo-controlled trial." | 5.05 | Propranolol therapy for essential tremor of the head. ( Koller, WC, 1984) |
| "The effect of the withdrawal of long-term beta-adrenoceptor blockade on pulse rate and finger tremor was studied in 27 patients who had been treated for 2 years following an uncomplicated myocardial infarction with either atenolol, propranolol or placebo." | 5.05 | Effect on finger tremor of withdrawal of long-term treatment with propranolol or atenolol. ( Birmingham, AT; Roland, JM; Wharrad, HJ; Williams, EJ; Wilson, CG, 1984) |
| "The efficacy of propranolol and metoprolol in the treatment of essential tremor was compared in a double blind crossover placebo-controlled study in 16 patients." | 5.05 | Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor. ( Calzetti, S; Findley, LJ; Perucca, E; Richens, A, 1982) |
| "Single oral doses of propranolol (120 mg), metoprolol (150 mg) and placebo were given in a randomised, double-blind fashion to 23 patients with essential tremor." | 5.05 | Metoprolol and propranolol in essential tremor: a double-blind, controlled study. ( Calzetti, S; Findley, LJ; Gresty, MA; Perucca, E; Richens, A, 1981) |
| "We studied chronic oral propranolol therapy and placebo in seven patients with essential voice tremor." | 5.05 | Essential voice tremor: treatment with propranolol. ( Graner, D; Koller, W; Mlcoch, A, 1985) |
| "Three different beta-adrenoreceptor antagonists--propranolol, sotalol, and atenolol--were compared in a double-blind study with placebo in nine patients with essential tremor." | 5.04 | beta-Adrenoreceptor antagonists in essential tremor. ( Jefferson, D; Jenner, P; Marsden, CD, 1979) |
| "The effects of 120 mg propranolol and 15 mg pindolol daily on positional tremor of 24 patients with benign essential tremor were analyzed with a double-blind crossover trial and electrical tremor recording." | 5.04 | Comparison between the effects of pindolol and propranolol on essential tremor. ( Fogelholm, R; Larsen, A; Teravainen, H, 1977) |
| "The effect of the beta-adrenergic blocking agent propranolol was tested on positional tremor occurring during acute alcohol withdrawal using a double-blind crossover method and electrical recording of tremor amplitude and frequency." | 5.04 | Effect of propranolol on acute withdrawal tremor in alcoholic patients. ( Larsen, A; Teräväinen, H, 1976) |
| "In a double-blind crossover study 12 patients with essential tremor were treated with propranolol and a placebo; 8 improved with propranolol and 3 with the placebo; the degree of improvement with propranolol was greater." | 5.04 | Long-term therapy of essential tremor with propranolol. ( Murray, TJ, 1976) |
| "Practolol, propranolol, and placebo have been tested on an objective test of lithium induced tremor." | 5.04 | Beta blockade in lithium tremor. ( Bailey, J; Coppen, AJ; Kellett, JM; Metcalfe, M, 1975) |
| "The investigators tested the effect of 120 mg propranolol daily on 21 patients with essential tremor using a double-blind cross-over method and electrical recording of tremor amplitude and frequency." | 5.04 | Effect of propranolol on essential tremor. ( Fogelholm, R; Larsen, A; Teräväinen, H, 1976) |
| "A double-blind trial of propranolol, in a dosage of 120 mg a day, and placebo was conducted in 11 patients with essential tremor." | 5.04 | Essential tremor: treatment with propranolol. ( Loewenson, RB; Tolosa, ES, 1975) |
| "A double blind trial of a single 40 mg dose of the beta adrenergic blocking agent propranolol in the treatment of essential tremor produced significant reduction of tremor in four of five patients, but this effect was transient and had considerably diminished within four hours." | 5.04 | Effect of the beta adrenergic blocking agent propranolol on essential tremor. ( Cooper, R; Hewer, RL; Morgan, MH, 1973) |
| "In this systematic review we present information relating to the effectiveness and safety of the following interventions: adding mirtazepine to other antitremor drugs; benzodiazepines; beta-blockers other than propranolol; botulinum A toxin-haemagglutinin complex; calcium channel blockers; carbonic anhydrase inhibitors; clonidine; flunarizine; gabapentin; isoniazid; Phenobarbital; primidone; propranolol; and topiramate." | 4.84 | Essential tremor. ( Ferreira, JJ; Sampaio, C, 2007) |
| " The beta-carboline harmine, which induces hypothermia and tremor, is metabolized by CYP2D6 to the non-hypothermic/non-tremorgenic harmol." | 3.96 | Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice. ( Gonzalez, FJ; Miksys, S; Stocco, MR; Tolledo, C; Tyndale, RF; Wadji, FB, 2020) |
| " We measured the effects of a selective blocker of I(T) (ethosuximide) in healthy subjects on the amplitude and frequency of saccadic oscillations evoked by eye closure and of a nonselective blocker of I(h) and I(T) (propronolol) in a patient with microsaccadic oscillation and limb tremor syndrome (mSOLT)." | 3.77 | The effects of ion channel blockers validate the conductance-based model of saccadic oscillations. ( Leigh, RJ; Miura, K; Optican, LM; Ramat, S; Shaikh, AG; Zee, DS, 2011) |
| "Harmaline-induced tremor in rodents is a model of essential tremor." | 3.75 | Pharmacological characterization of harmaline-induced tremor activity in mice. ( Foreman, MM; Hanania, T; Malekiani, SA; Olivier, B; Paterson, NE, 2009) |
| "The effects of nicotinic and beta-adrenergic receptor antagonists on tail-tremor induced by repeated nicotine administration were investigated in rats." | 3.69 | Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. ( Gomita, Y; Kawasaki, H; Oishi, R; Suemaru, K; Tanizaki, Y, 1997) |
| "The repeated administration of nicotine at small doses, which do not produce whole body tremor or convulsion, causes tremor only in the tail (tail-tremor) of rats." | 3.69 | [Assessment of anti-tremorogenic drugs--nicotine-induced tail-tremor model]. ( Gomita, Y; Kawasaki, H; Suemaru, K, 1997) |
| "The cases of two asthmatic adolescents who overdosed on albuterol are presented." | 3.68 | Propranolol treatment of albuterol poisoning in two asthmatic patients. ( Henretig, F; Joffe, M; Ramoska, EA; Spiller, HA, 1993) |
| "The effect of arotinolol, a peripherally acting beta-adrenergic-blocking agent, on postural or kinetic tremor was studied in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism." | 3.68 | Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys. ( Kuno, S; Mizuta, E; Nishida, J; Takechi, M, 1992) |
| "We treated 28 patients (16 women and 12 men) who had essential tremor with methazolamide." | 3.68 | Treatment of essential tremor with methazolamide. ( Caviness, JN; Daube, JR; Miller, PM; Muenter, MD, 1991) |
| "Despite a large number of studies demonstrating the effectiveness of propranolol in relieving essential tremor (ET) the long-term therapeutic outcome of these patients remains poorly defined." | 3.68 | Clinical and computer-based assessment of long-term therapeutic efficacy of propranolol in essential tremor. ( Baratti, M; Calzetti, S; Fava, R; Sasso, E, 1990) |
| "Non-selective adrenergic beta-blocking drugs prevented isoproterenol enhancement of essential tremor amplitude far more effectively than beta-1-selective blockers." | 3.67 | Beta-blockers in isoproterenol-enhanced essential tremor. ( Teräväinen, H, 1984) |
| "We analyzed effects of metoprolol tartrate and propranolol hydrochloride on 23 patients with essential tremor." | 3.67 | Metoprolol compared with propranolol in the treatment of essential tremor. ( Biary, N; Koller, WC, 1984) |
| "We studied the acute and chronic effects of propranolol and primidone in essential tremor by administering long-acting propranolol (80 to 160 mg/d) and primidone (50 to 250 mg/d) to 50 patients." | 3.67 | Acute and chronic effects of propranolol and primidone in essential tremor. ( Koller, WC; Vetere-Overfield, B, 1989) |
| "Propranolol in low doses antagonized and in higher doses facilitated oxotremorine-induced tremor (Oxo-tremor) in mice." | 3.67 | Cholinergic involvement in the modulation of oxotremorine-tremor in mice by propranolol. ( Alkondon, M; Ray, A; Sen, P, 1985) |
| "The tremorogenic effect of nicotine was studied in control rats and in rats withdrawn for 16-48 h from six to nine days' ethanol administration." | 3.67 | Ethanol withdrawal tremor potentiates the tremorogenic action of nicotine. ( Gothóni, P; Ikola, W, 1985) |
| "The effect of beta-adrenoceptor antagonists, varying in lipophilicity and receptor selectivity, were studied on tremor elicited by L-5-hydroxytryptophan (L-5-HTP) in rats pretreated with a peripherally acting decarboxylase inhibitor and a monoamine oxidase inhibitor, or by the directly acting 5-HT agonist 5-methoxy-N,N-dimethyltryptamine (5-MeODMT)." | 3.67 | Blockade of central beta-adrenoceptors attenuates tremor induced by 5-hydroxytryptamine (5-HT)-receptor activation in rats. ( Hallberg, H, 1987) |
| "Tremor induced by TRH and oxotremorine was recorded by a capacitance transducer, and its intensity and frequency were evaluated using power arrays." | 3.67 | [Power spectral analysis of tremor induced by TRH and oxotremorine in mice]. ( Fukuda, T; Izumi, K; Koja, T; Nomoto, M; Shimizu, T, 1986) |
| "An 80-year-old man who had had plaque-type psoriasis for 40 years experienced a rapid onset of generalized pustular psoriasis three days after initiation of propranolol hydrochloride therapy." | 3.67 | Generalized pustular psoriasis provoked by propranolol. ( Farber, EM; Hu, CH; Miller, AC; Peppercorn, R, 1985) |
| "The effect of doses of propranolol hydrochloride, 80 to 800 mg/day, was investigated in 15 patients with essential tremor." | 3.67 | Dose-response relationship of propranolol in the treatment of essential tremor. ( Koller, WC, 1986) |
| "Long-acting propranolol (propranolol-LA) was compared with propranolol in divided doses in 18 patients with essential tremor." | 3.67 | Long-acting propranolol in essential tremor. ( Koller, WC, 1985) |
| "We studied the effects of a single oral dose (120 mg) of propranolol on essential tremor in 12 patients." | 3.67 | Time course of a single oral dose of propranolol in essential tremor. ( Koller, WC; Royse, VL, 1985) |
| "The tremorogenic effect of nicotine was studied in control rats and in rats withdrawn for 16-48 h from chronic ethanol administration." | 3.66 | Hypersensitivity to the tremorogenic action of nicotine in rats withdrawn from ethanol. ( Gothóni, P, 1983) |
| "Primidone given to a patient for epilepsy produced an unexpected reduction in benign familial tremor." | 3.66 | Benign familial tremor treated with primidone. ( O'Brien, MD; Toseland, PA; Upton, AR, 1981) |
| "Assessment of an elderly depressed patient with an imipramine-induced tremor led to the conclusions that imipramine tremor (1) can be severe and incapacitating, (2) is most pronounced early in the treatment, (3) does not seem to be dose-related, and (4) is readily reversible with a beta-adrenergic blocking agent." | 3.66 | Imipramine-induced tremor: effects of a beta-adrenergic blocking agent. ( Greden, JF; Kronfol, Z; Zis, AP, 1983) |
| "The beta-1 selective, hydrophilic adrenoceptor blocking drug atenolol (100 mg daily) was compared to the non-selective, lipid-soluble beta-blocker propranolol (240 mg daily), and to placebo, in a double-blind cross-over study in 24 patients with essential tremor." | 3.66 | Atenolol vs. propranolol in essential tremor. A controlled, quantitative study. ( Calne, DB; Larsen, TA; Teräväinen, H, 1982) |
| "Five patients with essential tremor were treated with increasing daily doses of propranolol." | 3.66 | Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels. ( Jansen, EC; Paulson, OB; Steiness, E; Sørensen, PS, 1981) |
| "The role of peripheral catecholamines in mediating the pressor and tremorigenic effects of oxotremorine were investigated in conscious rats." | 3.66 | Peripheral catecholamines mediate certain responses to central cholinergic receptor stimulation by oxotremorine. ( Kopin, IJ; Weinstock, M; Zavadil, AP, 1980) |
| "The relationship between plasma propranolol concentration and relief of essential tremor was examined in 11 patients during treatment with oral racemic propranolol in doses of 30 to 640 mg/day." | 3.66 | Relationship between plasma propranolol concentration and relief of essential tremor. ( Jefferson, D; Jenner, P; Marsden, CD, 1979) |
| "Oxotremorine, a specific stimulant of central muscarinic acetylcholine receptors, inhibited lateral hypothalamic self-stimulation at a dose-level less than one-tenth of that necessary to produce body tremor." | 3.66 | Central cholinergic mechanisms in electrical self-stimulation and in drug-induced tremor in rats. ( Herberg, LJ; Wishart, TB, 1979) |
| "In addition to the various possibilities of influencing lithium tremor, experience gathered from the application of beta-receptor blockers is reported, and concepts investigated on the potential genesis and working mechanisms." | 3.65 | [Lithium tremor-combination treatment with beta receptor blockaders]. ( König, L, 1975) |
| " The effect of various agents injected into the cerebral ventricles of the mouse, upon the tremor and hypothermia produced by oxotremorine (0." | 3.65 | Modification of oxotremorine tremor and hypothermia by injections of drugs into the cerebral ventricles of the mouse. ( Doggett, NS; O'Farrell, SA, 1976) |
| "To study the mechanisms by which propranolol suppresses essential tremor, accelerometric recordings were made from four normal subjects and eight patients with that tremor, and small amounts of isoproterenol and propranolol were infused intravenously or into one brachial artery." | 3.65 | Beta-adrenergic mechanisms in action tremor. ( Growdon, JH; Shahani, BT; Young, RR, 1975) |
| " The influence of propranolol on the neuromuscular, tremor-producing and muscarinic effects of oxotremorine was examined." | 3.65 | Antioxotremorine action of propranolol. ( Ganguly, DK, 1976) |
| "Lithium tremor is an irregular, nonrhythmic tremor of the distal extremities, variable in both intensity and frequency." | 3.65 | Control of lithium tremor with propranolol. ( Lapierre, YD, 1976) |
| " In rats the effect of drugs on oxotremorine tremor and oxotremorine-induced increase in brain acetylcholine has been investigated." | 3.65 | Effects of drugs on tremor and increase in brain acetylcholine produced by oxotremorine in the rat. ( Cox, B; Potkonjak, D, 1970) |
| "Medications useful for treating tremor are discussed in this review, including those for action tremor as seen in essential tremor, the resting tremor of Parkinson's disease, orthostatic tremor, cerebellar tremor, Holmes tremor, dystonic tremor, and drug-induced tremors." | 2.82 | Medications used to treat tremors. ( Frei, K; Truong, DD, 2022) |
| "Atropine was administered before all studies to induce parasympathetic blockade." | 2.68 | Racial differences in beta-adrenoceptor-mediated responsiveness. ( Burlew, BS; Johnson, JA; Stiles, RN, 1995) |
| "Tremor was assessed via accelerometry and surface EMG." | 2.68 | 'Atypical' tremor. ( Byth, K; Einstein, R; Henderson, JM; Jackson, DM; Morris, JG, 1995) |
| "This study investigated the effects of isamoltane on the changes induced by cumulative doses of inhaled albuterol (salbutamol) on bronchomotor tone, skeletal muscle, circulatory system, and metabolism after single (day 1) and multiple dosing (day 7) in 15 healthy subjects." | 2.67 | Assessment of beta-adrenergic receptor blockade after isamoltane, a 5-HT1-receptor active compound, in healthy volunteers. ( Bauer, K; Dietersdorfer, F; Kaik, G, 1993) |
| "In the Parkinson's disease group studied, the frequency, EMG pattern of bursts, and response to L-Dopa were similar for the two tremors (median improvement of RT by 70% and PT by 61%)." | 2.67 | Postural tremor of Parkinson's disease. ( Byth, K; Einstein, R; Henderson, JM; Jackson, D; Morris, JG; Yiannikas, C, 1994) |
| "Pre-treatment with propranolol LA resulted in a significant pressor response and a bradycardia during hypoglycaemia." | 2.67 | Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects. ( Heller, SR; Kerr, D; MacDonald, IA; Tattersall, RB, 1990) |
| " Dose-response curves were constructed and the doses required to increase heart rate by 25 beats min-1, finger tremor by 200%, calf blood flow by 0." | 2.67 | A dose-ranging study to evaluate the beta-adrenoceptor selectivity of single doses of betaxolol. ( Irvine, NA; Lipworth, BJ; McDevitt, DG, 1990) |
| " Dose-response curves were constructed for the changes in heart rate, finger tremor, blood pressure and forearm blood flow produced by each infusion." | 2.66 | Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. ( Finch, MB; McNeill, AJ; O'Connor, PC; Pringle, TH; Riddell, JG; Shanks, RG, 1986) |
| " Propranolol, which showed the strongest anti-tremor effect, had no ISA, but its long-term administration induced symptoms of heart failure, such as pretibial oedema, in most cases." | 2.66 | Comparative studies on the effects of beta-adrenergic blockers in essential tremor. ( Ogawa, N; Takayama, H; Yamamoto, M, 1987) |
| "Essential tremor is not a benign condition; disability can be only partly reversed with drug therapy." | 2.66 | Disability in essential tremor: effect of treatment. ( Biary, N; Cone, S; Koller, W, 1986) |
| "6 Atenolol 60 mg was the only drug to allow a fenoterol airway response similar to placebo." | 2.65 | Assessment of beta-adrenoceptor antagonists in asthmatic patients. ( Alpers, JH; Crockett, AJ; Latimer, KM; McIntyre, EL; Ruffin, RE; Ward, HE, 1982) |
| "Amantadine was moderately effective, but cyproheptadine, diphenhydramine, and benztropine gave little or no relief." | 2.65 | Treatment of valproate tremors. ( Bauman, AW; Hammond, EJ; Karas, BJ; Wilder, BJ, 1983) |
| "Propranolol and practolol were equally effective, and better than placebo, at relieving the patients general well-being as well as the tachycardia, subjective and objective tremor, skin warmness and moistness and the intensity of the thyroid bruit." | 2.64 | The effects of propranolol, practolol, and placebo on the clinical manifestations of thyrotoxicosis. ( Chapdelaine, A; Coulombe, R; LeLorier, J, 1976) |
| "Tremor is one of the most frequent neurological signs." | 2.44 | [Tremor]. ( Deuschl, G; Raethjen, J, 2007) |
| "Tremor is often a disabling primary condition or secondary to another disorder." | 2.43 | Pharmacological treatment of disabling tremor. ( Charles, PD; Duffis, EI; Schadt, CR, 2005) |
| "Tremor is a common movement disorder yet many physicians struggle with its terminology as well as with its treatment." | 2.42 | Tremor--easily seen but difficult to describe and treat. ( Grimes, DA, 2003) |
| "Tremor-predominant Parkinson's disease is characterised by prominent tremor of one or more limbs with a relative lack of significant rigidity and bradykinesia." | 2.41 | Tremor-predominant Parkinson's disease. Approaches to treatment. ( Koller, W; Marjama-Lyons, J, 2000) |
| "Essential tremor is the most prevalent adult-onset movement disorder, and is also regarded as one of the most common neurological disorders of adults, with a prevalence that is similar to or greater than that of stroke, Alzheimer disease, migraine headache, and lumbosacral pain syndromes." | 2.40 | A new twist for stopping the shakes? Revisiting GABAergic therapy for essential tremor. ( Louis, ED, 1999) |
| "This tremor is normally recordable at a stable frequency of 8-10 Hz, though this can be influenced by age, the amplitude can vary substantially." | 2.39 | [Most frequent causes for hand tremor in clinical practice]. ( Málly, J, 1995) |
| "Tremor is an involuntary oscillation of body parts that may be physiologic or pathologic." | 2.37 | Diagnosis and treatment of tremors. ( Koller, WC, 1984) |
| "Physiologic tremor is present in normal persons and is asymptomatic." | 2.36 | Physiologic and pathologic tremors. Diagnosis, mechanism, and management. ( Fahn, S; Jankovic, J, 1980) |
| "Harmaline-induced tremor is an easily provoked model for the development of new therapies for essential tremor (ET)." | 1.91 | Mapping Pharmacologically Evoked Neurovascular Activation and Its Suppression in a Rat Model of Tremor Using Functional Ultrasound: A Feasibility Study. ( Alizad, A; Chang, SY; Fatemi, M; Lee, J; Nayak, R; Sotoudehnia, S, 2023) |
| " The majority of our cases made some change in their daily medication dosage during the course of the study - 73." | 1.72 | Prospective, longitudinal analysis of medication use in a cohort of elderly essential tremor cases. ( Berry, DS; Delgado, N; Hernandez, DI; Louis, ED, 2022) |
| "Orthostatic tremor (OT) and cerebellar ataxia are uncommon and difficult to treat." | 1.43 | Secondary orthostatic tremor in the setting of cerebellar degeneration. ( Jacoby, N; Pullman, SL; Sarva, H; Saunders-Pullman, R; Severt, WL, 2016) |
| "Although tremor has multiple sources, it is partly central in origin, reflecting a component of motoneuron discharge at this frequency." | 1.38 | Beta-adrenergic modulation of tremor and corticomuscular coherence in humans. ( Baker, MR; Baker, SN, 2012) |
| "Tremor is a common feature in patients with Kennedy's disease and has characteristics similar to those of essential tremor." | 1.37 | Tremor in X-linked recessive spinal and bulbar muscular atrophy (Kennedy's disease). ( Dias, FA; Munhoz, RP; Raskin, S; Teive, HA; Werneck, LC, 2011) |
| "Initial manifestations of Huntington's disease (HD) are varied and chorea is not always the first motor symptom." | 1.36 | [Postural tremor as first symptom of Huntington disease]. ( Bernard, E; Broussolle, E; Thobois, S, 2010) |
| "Infantile Tremor Syndrome is a distinct clinical entity most commonly seen in Indian Subcontinent." | 1.33 | Scurvy in infantile tremor syndrome. ( Hakeem, MA; Patil, MM; Ratageri, VH; Shepur, TA, 2005) |
| "We report on four cases of primary orthostatic tremor." | 1.31 | [Primary orthostatic tremor: report of 4 cases]. ( Cavallazzi, LO; Machado, SN; Matosinho, P; Pio, FJ, 2000) |
| "The tremor was refractory to pharmacotherapy (clonazepam, propranolol, and levodopa), but was reduced after implantation of a thalamic stimulator device." | 1.30 | Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage. ( Bakke, SJ; Nyberg-Hansen, R; Shepherd, GM; Tauböll, E, 1997) |
| "These tremors were diagnosed as 'forme fruste' of the essential tremor, not the incipient stage of Parkinson's disease." | 1.28 | Orthostatic tremor associated with voice tremor. ( Imai, H; Mizuno, Y; Ninomiya, C; Seki, K; Yokota, J, 1992) |
| "The interval between head trauma to onset of symptoms was 1 to 4 weeks." | 1.28 | Post-traumatic tremor. ( Biary, N; Cleeves, L; Findley, L; Koller, W, 1989) |
| " The dose-response curves constructed with intra-arterial or intravenous isoprenaline behave similarly in the presence of both atenolol 50 mg and propranolol 40 mg." | 1.27 | Enhancement of physiological finger tremor by intravenous isoprenaline infusions in man: evaluation of its role in the assessment of beta-adrenoceptor antagonists. ( Arnold, JM; McDevitt, DG, 1984) |
| " Satisfactory dose-response curves could be constructed for the isoprenaline enhanced increases in finger tremor." | 1.27 | An assessment of physiological finger tremor as an indicator of beta-adrenoceptor function. ( Arnold, JM; McDevitt, DG, 1983) |
| "The tremor was coarse, irregular, and unrelated to proprioception loss, muscle weakness, or fatigue; it appeared to represent disease activity or an early sign of a new relapse." | 1.27 | Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management. ( Dalakas, MC; Engel, WK; Teräväinen, H, 1984) |
| "Tongue tremor is a common finding in some essential tremor patients but often there are no symptoms." | 1.27 | Essential tongue tremor. ( Biary, N; Koller, WC, 1987) |
| "Tremor was quantified 8 hr later by spectral analysis of whole body movements." | 1.27 | Modulation of p,p'-DDT-induced tremor by catecholaminergic agents. ( Herr, DW; Tilson, HA, 1987) |
| "Essential tremor is a common disorder whose aetiology is unknown." | 1.27 | Essential tremor. ( Findley, LJ, 1986) |
| "Propranolol impeded the increase in MV values in all three axes, significantly those in the z axis (vertical), the differences in MV values between the two measurements being minimal in the beta-receptor blocked group." | 1.27 | The effect of propranolol on whole-body microvibrations during examination stress. ( Gerber, H; Koller, EA; Studer, R; Stüssi, E, 1986) |
| "The tremor was improved by alcohol or propranolol in six patients." | 1.27 | Writing tremor: its relationship to benign essential tremor. ( Cowan, JM; Kachi, T; Marsden, CD; Rothwell, JC, 1985) |
| "Treatment with haloperidol is effective but associated with a high incidence of side effects." | 1.26 | Tics and tremors. ( Golden, GS; Hood, OJ, 1982) |
| "Essential tremor is less incapacitating than parkinsonism and less inexorably progressive." | 1.26 | Benign essential tremor: features that aid in diagnosis. ( Paulson, GW, 1982) |
| " Observed on four drug-induced behavior categories, it was found that both clonidine and propranolol attenuated the toxic effects of relatively low dose levels of digitoxin, while at higher digitoxin dose levels only propranolol was able to reduce significantly the ED50 and the LD50." | 1.26 | Effect of age, clonidine or propranolol on behavioral toxicity induced with digitoxin in mice. ( Felleman, VH; Palfai, T, 1982) |
| "The typical 'tremor-at-rest' of Parkinson's disease--3-7 Hz activity which alternates between antagonistic muscles--is suppressed, at least briefly, during voluntary activity, at which time typical 8--12 Hz 'physiological tremor' may be seen." | 1.26 | Physiological and pharmacological aids in the differential diagnosis of tremor. ( Shahani, BT; Young, RR, 1976) |
| "Progress in the treatment of action myoclonus is especially noteworthy and has led to the implication of serotonin deficit in the pathophysiology of this syndrome." | 1.26 | New approaches in the management of hyperkinetic movement disorders. ( Fahn, S, 1977) |
| "Propranolol alone was more effective than either chlordiazepoxide or a combination of chlordiazepoxide and propranolol in alleviating the symptoms of the alcohol withdrawal syndrome." | 1.26 | Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal. ( Degani, NC; Sellers, EM; Zilm, DH, 1977) |
| "Resting tremor is present when the hands are at rest; it disappears with movement." | 1.26 | The shaking patient. Diagnosis and management of tremor. ( McKinney, AS, 1977) |
| " The method quickly produced accurate and reproducible dose-response curves." | 1.25 | Use of cumulative dose-response curves in potency comparisons of sympathomimetic amines on the cat soleus muscle. ( Nott, MW; Raper, C, 1972) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 199 (74.53) | 18.7374 |
| 1990's | 36 (13.48) | 18.2507 |
| 2000's | 13 (4.87) | 29.6817 |
| 2010's | 12 (4.49) | 24.3611 |
| 2020's | 7 (2.62) | 2.80 |
| Authors | Studies |
|---|---|
| Frei, K | 1 |
| Truong, DD | 1 |
| Lee, J | 2 |
| Kim, J | 1 |
| Cortez, J | 1 |
| Chang, SY | 2 |
| Delgado, N | 1 |
| Berry, DS | 1 |
| Hernandez, DI | 1 |
| Louis, ED | 2 |
| Roizenblatt, M | 1 |
| Gehlbach, PL | 1 |
| da Silveira Saraiva, V | 1 |
| Nakanami, MH | 1 |
| da Cruz Noia, L | 1 |
| Watanabe, SES | 1 |
| Yasaki, ES | 1 |
| Passos, RM | 1 |
| Magalhães Junior, O | 1 |
| Fernandes, RAB | 1 |
| Stefanini, FR | 1 |
| Caiado, R | 1 |
| Jiramongkolchai, K | 1 |
| Wolf, M | 1 |
| Eid Farah, M | 1 |
| Belfort Junior, R | 1 |
| Maia, M | 1 |
| Lv, Y | 1 |
| Wang, M | 1 |
| Yang, J | 1 |
| Shi, J | 1 |
| Xuan, T | 1 |
| Zhang, J | 1 |
| Du, D | 1 |
| Cheng, J | 1 |
| Li, H | 1 |
| Nayak, R | 1 |
| Sotoudehnia, S | 1 |
| Fatemi, M | 1 |
| Alizad, A | 1 |
| Stocco, MR | 1 |
| Tolledo, C | 1 |
| Wadji, FB | 1 |
| Gonzalez, FJ | 1 |
| Miksys, S | 1 |
| Tyndale, RF | 1 |
| Guglielmino, G | 1 |
| Moraes, BT | 1 |
| Villanova, LC | 1 |
| Padovani, M | 1 |
| Biase, NG | 1 |
| Aleva, FE | 1 |
| de Jager, CPC | 1 |
| Ronan, GP | 1 |
| Ronan, N | 1 |
| McGettigan, S | 1 |
| Browne, G | 1 |
| Sarva, H | 1 |
| Severt, WL | 1 |
| Jacoby, N | 1 |
| Pullman, SL | 1 |
| Saunders-Pullman, R | 1 |
| Gupta, R | 1 |
| Pathak, A | 1 |
| Mandliya, J | 1 |
| Mandliya, P | 1 |
| Sonker, P | 1 |
| Thomas, RM | 1 |
| Gobbur, RH | 1 |
| Ferreira, JJ | 1 |
| Sampaio, C | 1 |
| Paterson, NE | 1 |
| Malekiani, SA | 1 |
| Foreman, MM | 1 |
| Olivier, B | 1 |
| Hanania, T | 1 |
| Drakaki, A | 1 |
| Habib, M | 1 |
| Sweeney, AT | 1 |
| Bernard, E | 1 |
| Broussolle, E | 1 |
| Thobois, S | 1 |
| Lees, M | 1 |
| Regier, L | 1 |
| Jensen, B | 1 |
| Struble, LM | 1 |
| Dias, FA | 1 |
| Munhoz, RP | 1 |
| Raskin, S | 1 |
| Werneck, LC | 1 |
| Teive, HA | 1 |
| Shaikh, AG | 1 |
| Zee, DS | 1 |
| Optican, LM | 1 |
| Miura, K | 1 |
| Ramat, S | 1 |
| Leigh, RJ | 1 |
| Baker, MR | 1 |
| Baker, SN | 1 |
| Grimes, DA | 1 |
| Schadt, CR | 1 |
| Duffis, EI | 1 |
| Charles, PD | 1 |
| Ratageri, VH | 1 |
| Shepur, TA | 1 |
| Patil, MM | 1 |
| Hakeem, MA | 1 |
| Raethjen, J | 1 |
| Deuschl, G | 1 |
| Hanu-Cernat, LM | 1 |
| Rehman, KU | 1 |
| Sittampalam, G | 1 |
| Whear, NM | 1 |
| Foley, TH | 2 |
| Marsden, CD | 15 |
| Owen, DA | 5 |
| McAllister, RG | 4 |
| Spoerlein, MT | 1 |
| VanderWende, C | 1 |
| Calzetti, S | 8 |
| Findley, LJ | 13 |
| Perucca, E | 8 |
| Richens, A | 8 |
| Ljung, O | 2 |
| Gresty, MA | 4 |
| Paul, EA | 1 |
| Obukhov, GA | 1 |
| Pickles, H | 2 |
| Fish, A | 1 |
| Corbett, JL | 1 |
| Ruffin, RE | 1 |
| McIntyre, EL | 1 |
| Latimer, KM | 1 |
| Ward, HE | 1 |
| Crockett, AJ | 1 |
| Alpers, JH | 1 |
| Patel, L | 1 |
| Turner, P | 1 |
| Gerstenbrand, F | 2 |
| Klingler, D | 1 |
| Poewe, W | 2 |
| Kulik, AV | 1 |
| Wilbur, R | 1 |
| Teräväinen, H | 10 |
| Cleeves, L | 5 |
| Arnold, JM | 2 |
| McDevitt, DG | 3 |
| Mignot, B | 1 |
| Ollat, H | 1 |
| Contamin, F | 1 |
| Baruzzi, A | 2 |
| Procaccianti, G | 2 |
| Martinelli, P | 1 |
| Riva, R | 2 |
| Denoth, F | 1 |
| Montanaro, N | 1 |
| Lugaresi, E | 1 |
| Larsen, TA | 4 |
| Koller, WC | 16 |
| Karas, BJ | 1 |
| Wilder, BJ | 1 |
| Hammond, EJ | 1 |
| Bauman, AW | 1 |
| Albani, F | 1 |
| Baldrati, A | 1 |
| Cortelli, P | 1 |
| Wharrad, HJ | 2 |
| Birmingham, AT | 2 |
| Wilson, CG | 1 |
| Williams, EJ | 1 |
| Roland, JM | 1 |
| Olivera, AA | 1 |
| Kiefer, MW | 1 |
| Biary, N | 7 |
| Zubenko, GS | 1 |
| Cohen, BM | 1 |
| Lipinski, JF | 1 |
| Ward, K | 1 |
| Potamianos, G | 1 |
| Peters, TJ | 1 |
| Gothóni, P | 2 |
| Dalakas, MC | 1 |
| Engel, WK | 1 |
| Mattson, RH | 1 |
| Cramer, JA | 1 |
| O'Brien, MD | 1 |
| Upton, AR | 1 |
| Toseland, PA | 1 |
| Nemeroff, CB | 1 |
| Evans, DL | 1 |
| Kronfol, Z | 1 |
| Greden, JF | 1 |
| Zis, AP | 1 |
| Golden, GS | 1 |
| Hood, OJ | 1 |
| Jankovic, J | 2 |
| Fahn, S | 2 |
| Murray, TJ | 3 |
| Paulson, GW | 1 |
| Jefferson, D | 5 |
| Leigh, N | 1 |
| Jenner, P | 4 |
| Kalayam, B | 1 |
| Shamoian, CA | 1 |
| Palfai, T | 1 |
| Felleman, VH | 1 |
| Calne, DB | 1 |
| Sørensen, PS | 1 |
| Paulson, OB | 1 |
| Steiness, E | 1 |
| Jansen, EC | 1 |
| Weinstock, M | 2 |
| Zavadil, AP | 1 |
| Kopin, IJ | 1 |
| Delwaide, PJ | 3 |
| Anton, RF | 1 |
| Schou, M | 4 |
| Málly, J | 4 |
| Johnson, JA | 1 |
| Burlew, BS | 1 |
| Stiles, RN | 1 |
| Jiménez-Jiménez, FJ | 1 |
| Garcia-Ruiz, PJ | 1 |
| Cabrera-Valdivia, F | 1 |
| Metzer, WS | 1 |
| Paige, SR | 1 |
| Newton, JE | 1 |
| Bauer, K | 1 |
| Dietersdorfer, F | 1 |
| Kaik, G | 1 |
| Nguyen, PB | 1 |
| Hart, LL | 1 |
| Ramoska, EA | 1 |
| Henretig, F | 1 |
| Joffe, M | 1 |
| Spiller, HA | 1 |
| Stone, TW | 2 |
| Marchand, L | 1 |
| Henderson, JM | 3 |
| Einstein, R | 2 |
| Jackson, DM | 1 |
| Byth, K | 2 |
| Morris, JG | 2 |
| Bain, PG | 2 |
| Britton, TC | 1 |
| Rothwell, JC | 2 |
| Thompson, PD | 1 |
| Felice, KJ | 1 |
| Grunnet, ML | 1 |
| Grove, A | 1 |
| Lipworth, BJ | 2 |
| Humayun, MU | 1 |
| Rader, RS | 1 |
| Pieramici, DJ | 1 |
| Awh, CC | 1 |
| de Juan, E | 1 |
| Portmann, L | 1 |
| Van Melle, G | 1 |
| Haller, E | 1 |
| Ghika, JA | 1 |
| Suemaru, K | 2 |
| Kawasaki, H | 2 |
| Oishi, R | 1 |
| Gomita, Y | 2 |
| Tanizaki, Y | 1 |
| Shepherd, GM | 1 |
| Tauböll, E | 1 |
| Bakke, SJ | 1 |
| Nyberg-Hansen, R | 2 |
| Yiannikas, C | 1 |
| Jackson, D | 1 |
| Gironell, A | 1 |
| Kulisevsky, J | 1 |
| Barbanoj, M | 1 |
| López-Villegas, D | 1 |
| Hernández, G | 1 |
| Pascual-Sedano, B | 1 |
| Elman, MJ | 1 |
| Sugar, J | 1 |
| Fiscella, R | 1 |
| Deutsch, TA | 1 |
| Noth, J | 1 |
| Nyberg, M | 1 |
| Packo, K | 1 |
| Anderson, RJ | 1 |
| Soler, R | 1 |
| Vivancos, F | 1 |
| Muñoz-Torrero, JJ | 1 |
| Arpa, J | 1 |
| Barreiro, P | 1 |
| Cavallazzi, LO | 1 |
| Machado, SN | 1 |
| Matosinho, P | 1 |
| Pio, FJ | 1 |
| Marjama-Lyons, J | 1 |
| Koller, W | 6 |
| Masuhr, F | 1 |
| Wissel, J | 1 |
| Müller, J | 1 |
| Scholz, U | 1 |
| Banjar, WM | 1 |
| Gazzaz, J | 1 |
| Langley, RW | 1 |
| Bradshaw, CM | 1 |
| Szabadi, E | 1 |
| König, L | 1 |
| Shahani, BT | 3 |
| Young, RR | 8 |
| Bouvenot, G | 1 |
| Escande, M | 1 |
| Jouve, R | 1 |
| Delboy, C | 1 |
| Topliss, D | 1 |
| Bond, R | 1 |
| Larsson, S | 1 |
| Svedmyr, N | 1 |
| Markesbery, WR | 2 |
| Ware, RW | 2 |
| Howell, SM | 2 |
| Schoenen, J | 2 |
| Zilm, DH | 3 |
| Sellers, EM | 3 |
| Frecker, RC | 1 |
| Kunov, H | 1 |
| Kulkarni, SK | 1 |
| Kaul, PN | 1 |
| Wishart, TB | 1 |
| Herberg, LJ | 1 |
| Larsen, A | 3 |
| Fogelholm, R | 2 |
| Freund, G | 1 |
| Ellison, PH | 1 |
| Routledge, PA | 1 |
| Shand, DG | 1 |
| Degani, NC | 1 |
| Beasley, BA | 1 |
| Ford, DH | 1 |
| Dietrichson, P | 2 |
| Stensrud, P | 1 |
| Chapdelaine, A | 1 |
| Coulombe, R | 1 |
| LeLorier, J | 1 |
| McClure, CG | 1 |
| Davis, JN | 1 |
| McKinney, AS | 1 |
| Doggett, NS | 1 |
| O'Farrell, SA | 1 |
| Hornabrook, RW | 1 |
| Nagurney, JT | 1 |
| Kellett, JM | 1 |
| Metcalfe, M | 1 |
| Bailey, J | 1 |
| Coppen, AJ | 1 |
| Banna, NR | 1 |
| Kurkjian, R | 1 |
| Goldney, RD | 1 |
| Glew, EF | 1 |
| Rajput, AH | 1 |
| Jamieson, H | 1 |
| Hirsh, S | 1 |
| Quraishi, A | 1 |
| Sutherland, JM | 1 |
| Edwards, VE | 1 |
| Eadie, MJ | 1 |
| Growdon, JH | 2 |
| Koch-Weser, J | 1 |
| Silfverskiöld, B | 1 |
| Tolosa, ES | 1 |
| Loewenson, RB | 1 |
| Davis, DA | 1 |
| Landstrom, DL | 1 |
| Thong, NN | 1 |
| Ganguly, DK | 1 |
| MacLeod, SM | 1 |
| Lapierre, YD | 1 |
| Kuno, S | 1 |
| Mizuta, E | 1 |
| Nishida, J | 1 |
| Takechi, M | 1 |
| Sasso, E | 2 |
| Negrotti, A | 1 |
| Baratti, M | 2 |
| Fava, R | 2 |
| Yokota, J | 1 |
| Imai, H | 1 |
| Seki, K | 1 |
| Ninomiya, C | 1 |
| Mizuno, Y | 1 |
| Muenter, MD | 1 |
| Daube, JR | 1 |
| Caviness, JN | 1 |
| Miller, PM | 1 |
| Kerr, D | 1 |
| MacDonald, IA | 1 |
| Heller, SR | 1 |
| Tattersall, RB | 1 |
| Irvine, NA | 1 |
| Lou, JS | 1 |
| Hsu, YD | 1 |
| Chang, MK | 1 |
| Sung, SC | 1 |
| Hsein, HH | 1 |
| Deng, JC | 1 |
| Diener, HC | 1 |
| Vetere-Overfield, B | 1 |
| Caccia, MR | 1 |
| Osio, M | 1 |
| Galimberti, V | 1 |
| Cataldi, G | 1 |
| Mangoni, A | 1 |
| Pringle, TH | 2 |
| Riddell, JG | 2 |
| Shanks, RG | 2 |
| Alkondon, M | 1 |
| Ray, A | 1 |
| Sen, P | 1 |
| Ikola, W | 1 |
| O'Connor, PC | 1 |
| McNeill, AJ | 1 |
| Finch, MB | 1 |
| Abila, B | 1 |
| Wilson, JF | 1 |
| Marshall, RW | 1 |
| Huttunen, J | 2 |
| Hallberg, H | 1 |
| Espen, E | 1 |
| Ogawa, N | 1 |
| Takayama, H | 1 |
| Yamamoto, M | 1 |
| Patrick, JM | 1 |
| Findley, L | 1 |
| Golden, RN | 1 |
| Hoffman, J | 1 |
| Falk, D | 1 |
| Provenzale, D | 1 |
| Curtis, TE | 1 |
| Cone, S | 1 |
| Koja, T | 1 |
| Nomoto, M | 1 |
| Shimizu, T | 1 |
| Izumi, K | 1 |
| Fukuda, T | 1 |
| Herskovits, E | 1 |
| Figueroa, E | 1 |
| Mangone, C | 1 |
| Orebaugh, C | 1 |
| Lawson, L | 1 |
| Potempa, K | 1 |
| Bogin, RM | 1 |
| Nostrant, TT | 1 |
| Young, MJ | 1 |
| Glatt, S | 1 |
| Rubino, FA | 2 |
| Kostić, V | 1 |
| Pavlović, D | 1 |
| Nikolić, M | 1 |
| Gorman, WP | 1 |
| Cooper, R | 2 |
| Pocock, P | 1 |
| Campbell, MJ | 1 |
| Herbster, G | 1 |
| Topaktas, S | 1 |
| Onur, R | 1 |
| Dalkara, T | 1 |
| Herr, DW | 1 |
| Tilson, HA | 1 |
| Koller, EA | 1 |
| Studer, R | 1 |
| Gerber, H | 1 |
| Stüssi, E | 1 |
| Graner, D | 1 |
| Mlcoch, A | 1 |
| Hu, CH | 1 |
| Miller, AC | 1 |
| Peppercorn, R | 1 |
| Farber, EM | 1 |
| Royse, VL | 2 |
| Kachi, T | 1 |
| Cowan, JM | 1 |
| Kirk, L | 3 |
| Baastrup, PC | 3 |
| Gilligan, B | 1 |
| Balla, JI | 1 |
| Foster, JB | 2 |
| Kissel, P | 1 |
| Tridon, P | 1 |
| André, JM | 1 |
| Parkes, JD | 1 |
| Rees, JE | 1 |
| Scopa, J | 1 |
| Longley, BP | 1 |
| Floru, L | 1 |
| Whitlock, FA | 1 |
| Price, J | 1 |
| Jefferson, JW | 1 |
| Meadows, JC | 2 |
| Connor, JD | 1 |
| Rossi, GV | 2 |
| Baker, WW | 2 |
| Jacobi, H | 1 |
| Jurna, I | 1 |
| Nell, T | 1 |
| Schreyer, I | 1 |
| Sharma, PL | 1 |
| Watanabe, H | 1 |
| Munakata, H | 1 |
| Chen, SC | 1 |
| Kasuya, Y | 1 |
| Leslie, GB | 1 |
| Hayman, DG | 1 |
| Ireson, JD | 1 |
| Smith, S | 1 |
| Gilligan, BS | 1 |
| Veale, JL | 1 |
| Wodak, J | 1 |
| Dupont, E | 1 |
| Hansen, HJ | 1 |
| Dalby, MA | 1 |
| Morgan, MH | 1 |
| Hewer, RL | 1 |
| Winkler, GF | 2 |
| Sevitt, I | 2 |
| Wood, RW | 1 |
| Weiss, AB | 1 |
| Weiss, B | 1 |
| Barbeau, A | 1 |
| Drew, LR | 1 |
| Moon, JR | 1 |
| Buchanan, FH | 1 |
| Trivedi, CP | 1 |
| Sharma, RD | 1 |
| Castan, R | 1 |
| Sweet, RD | 1 |
| Blumberg, J | 1 |
| Lee, JE | 1 |
| Mc Dowell, FH | 1 |
| Cox, B | 2 |
| Potkonjak, D | 2 |
| Lalley, PM | 1 |
| Nott, MW | 1 |
| Raper, C | 1 |
| Schwab, RS | 1 |
| Achari, G | 1 |
| Sinha, SP | 1 |
| Gimlette, TM | 1 |
| Miller, TN | 1 |
| Avenarius, HJ | 1 |
| Stern, P | 1 |
| Basagić, E | 1 |
| Buljubasić, S | 1 |
| Lange, GW | 1 |
| Watson, RS | 1 |
| Aquilonius, SM | 1 |
| Tiselius, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| the Effects of Repetitive Transcranial Magnetic Stimulation and Mechanisms in Clinical Function of Essential Tremor[NCT06145932] | 40 participants (Anticipated) | Interventional | 2023-11-07 | Recruiting | |||
| Measuring Cortisol Levels in Persons With Parkinson's (PD)[NCT02727270] | 131 participants (Actual) | Observational | 2016-06-30 | Completed | |||
| Environmental Epidemiology of Essential Tremor[NCT04576676] | 1,497 participants (Actual) | Observational | 2020-07-02 | Completed | |||
| Propranolol as a Treatment for Impaired Awareness of Hypoglycemia in Type 1 Diabetes[NCT03161964] | Phase 2 | 2 participants (Actual) | Interventional | 2017-10-19 | Terminated (stopped due to Statistical power could not be achieved due to low enrollment.) | ||
| Deep braIn Stimulation for Tremor TractographIC Versus Traditional[NCT02491554] | 24 participants (Anticipated) | Interventional | 2015-08-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
21 reviews available for propranolol and Tremor
| Article | Year |
|---|---|
Medications used to treat tremors.
Topics: Ataxia; Essential Tremor; Humans; Parkinson Disease; Propranolol; Tremor | 2022 |
Essential tremor.
Topics: Double-Blind Method; Essential Tremor; Humans; Primidone; Propranolol; Tremor | 2007 |
Tremors: learning to stop the shakes.
Topics: Adrenergic beta-Antagonists; Alprazolam; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabap | 2010 |
Tremor--easily seen but difficult to describe and treat.
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Diagnosis, Differential; Essential Tremor; Humans; Pri | 2003 |
Pharmacological treatment of disabling tremor.
Topics: Botulinum Toxins, Type A; Dystonia; Essential Tremor; Humans; Parkinson Disease; Primidone; Proprano | 2005 |
[Tremor].
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Antiparkinson Agents; Botulinum Toxins; Cholinergic Ag | 2007 |
[Use of beta-adrenergic blockers in neurologic and psychiatric clinical practice].
Topics: Adrenergic beta-Antagonists; Alcoholism; Anti-Anxiety Agents; Cardiovascular Diseases; Humans; Hyper | 1981 |
Central actions of beta-adrenoceptor blocking drugs in man.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety Disorders; Behavior, Animal; Brain; Haplorhini; Humans | 1981 |
Diagnosis and treatment of tremors.
Topics: Cerebellar Diseases; Diagnosis, Differential; Ethanol; Humans; Parkinson Disease; Propranolol; Tremo | 1984 |
Physiologic and pathologic tremors. Diagnosis, mechanism, and management.
Topics: Alcoholic Beverages; Antiparkinson Agents; Cerebellar Diseases; Humans; Parkinson Disease; Propranol | 1980 |
Essential tremor.
Topics: Ethanol; Humans; Prognosis; Propranolol; Tremor | 1981 |
[Most frequent causes for hand tremor in clinical practice].
Topics: Aged; Aged, 80 and over; Aging; Female; Hand; Humans; Hypokinesia; Male; Parkinson Disease; Posture; | 1995 |
Dronabinol in tremor.
Topics: Age Factors; Dronabinol; Female; Humans; Male; Parkinson Disease; Primidone; Propranolol; Tremor | 1993 |
A new twist for stopping the shakes? Revisiting GABAergic therapy for essential tremor.
Topics: Acetates; Adult; Amines; Cyclohexanecarboxylic Acids; GABA Agonists; Gabapentin; gamma-Aminobutyric | 1999 |
Tremor-predominant Parkinson's disease. Approaches to treatment.
Topics: Acetates; Amantadine; Amines; Antiparkinson Agents; Botulinum Toxins; Cholinergic Antagonists; Clona | 2000 |
The presynaptic effect of beta-adrenoceptor antagonists on noradrenergic neurones.
Topics: Adrenal Medulla; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Electric Stimulation; | 1976 |
Aging and the extrapyramidal system.
Topics: Aged; Aging; Basal Ganglia Diseases; Chlorpromazine; Chorea; Dopamine; Frontal Lobe; Gait; Haloperid | 1976 |
The pharmacological management of essential tremor.
Topics: Adrenergic beta-Antagonists; Ethanol; Humans; Phenobarbital; Primidone; Propranolol; Tremor | 1986 |
Use of beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcoholism; Anxiety; Chlordiazepoxide; Di | 1974 |
Beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alcoholism; Amphetamine; Animals; Antidepressive Agents; | 1974 |
[Tremor].
Topics: Adolescent; Adult; Aged; Child; Humans; Posture; Propranolol; Tremor | 1974 |
88 trials available for propranolol and Tremor
| Article | Year |
|---|---|
Weight-adjusted caffeine and β-blocker use in novice versus senior retina surgeons: a self-controlled study of simulated performance.
Topics: Adrenergic beta-Antagonists; Caffeine; Cross-Sectional Studies; Double-Blind Method; Humans; Male; P | 2023 |
Cerebellar repetitive transcranial magnetic stimulation versus propranolol for essential tremor.
Topics: Cerebellum; Essential Tremor; Humans; Propranolol; Transcranial Magnetic Stimulation; Treatment Outc | 2023 |
Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors.
Topics: Adrenergic beta-Antagonists; Botulinum Toxins, Type A; Dystonic Disorders; Electromyography; Humans; | 2018 |
Peripheral beta-adrenergic receptors concerned with tremor.
Topics: Adult; Arteries; Blood Circulation; Bradykinin; Catecholamines; Epinephrine; Fingers; Forearm; Human | 1967 |
The response of essential tremor to propranolol: evaluation of clinical variables governing its efficacy on prolonged administration.
Topics: Adult; Aged; Cross-Sectional Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Placeb | 1983 |
Amplitude of benign essential tremor and response to propranolol.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Propranolol; Regression Analysis; Tremor | 1981 |
Propranolol and sotalol as antagonists of isoproterenol-enhanced physiologic tremor.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Dose-Response Relationship, Drug; Female; | 1981 |
Metoprolol in essential tremor.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Metoprolol; Propanolamines; Pro | 1981 |
Assessment of beta-adrenoceptor antagonists in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Female; Forced Expiratory Volume; Humans; Male | 1982 |
Beta adrenoreceptor antagonists in essential tremor.
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; M | 1984 |
Beta-adrenoreceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2 selective adrenoreceptor antagonist.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Fem | 1984 |
Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
Topics: Adult; Atenolol; Blood Pressure; Heart Rate; Humans; Male; Metoprolol; Physical Exertion; Propanolam | 1981 |
Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle | 1983 |
Effect of a single oral dose of propranolol on essential tremor: a double-blind controlled study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Hand; Heart Rate; Humans; Male; | 1983 |
Beta 1 versus nonselective blockade in therapy of essential tremor.
Topics: Adult; Clinical Trials as Topic; Female; Humans; Male; Metoprolol; Middle Aged; Outcome and Process | 1983 |
Nadolol in essential tremor.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; Nadolol; Placebos; Propano | 1983 |
Pharmacologic trials in the treatment of cerebellar tremor.
Topics: Adult; Cerebellar Diseases; Clinical Trials as Topic; Double-Blind Method; Ethanol; Humans; Isoniazi | 1984 |
Propranolol therapy for essential tremor of the head.
Topics: Clinical Trials as Topic; Head; Humans; Male; Middle Aged; Placebos; Propranolol; Tremor | 1984 |
Treatment of valproate tremors.
Topics: Amantadine; Cyproheptadine; Diphenhydramine; Humans; Propranolol; Tremor; Valproic Acid | 1983 |
Effect on finger tremor of withdrawal of long-term treatment with propranolol or atenolol.
Topics: Atenolol; Blood Pressure; Female; Fingers; Humans; Male; Middle Aged; Physical Exertion; Posture; Pr | 1984 |
Effect of alcohol on tremors: comparison with propranolol.
Topics: Adult; Cerebellar Diseases; Ethanol; Humans; Male; Middle Aged; Multiple Sclerosis; Parkinson Diseas | 1984 |
Propranolol and essential tremor: rôle of the membrane effect.
Topics: Adult; Cell Membrane; Clinical Trials as Topic; Depression, Chemical; Female; Heart Rate; Humans; Ma | 1982 |
Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor.
Topics: Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female | 1982 |
Metoprolol and propranolol in essential tremor: a double-blind, controlled study.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Hand; Heart Rate | 1981 |
Racial differences in beta-adrenoceptor-mediated responsiveness.
Topics: Adult; Analysis of Variance; Atropine; Black People; Blood Pressure; Electrocardiography; Exercise; | 1995 |
Nicardipine versus propranolol in essential tumor.
Topics: Adult; Aged; Cross-Over Studies; Female; Humans; Male; Middle Aged; Nicardipine; Propranolol; Tremor | 1994 |
Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
Topics: Aged; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Dyskine | 1993 |
Assessment of beta-adrenergic receptor blockade after isamoltane, a 5-HT1-receptor active compound, in healthy volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Albuterol; Dose-Response Relationship, Drug; Double-Blind Method | 1993 |
Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol.
Topics: Adenosine; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cro | 1995 |
'Atypical' tremor.
Topics: Benserazide; Child; Child, Preschool; Cross-Over Studies; Double-Blind Method; Drug Combinations; El | 1995 |
Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
Topics: Adrenergic Agents; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Bronchod | 1996 |
Quantitative measurement of the effects of caffeine and propranolol on surgeon hand tremor.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Caffeine; Central Nervous System Stimulants; Double-Bli | 1997 |
Propranolol as an adjunct therapy for hyperthyroid tremor.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Carbimazole; Cross-Over Studies; Double-Blin | 1997 |
Postural tremor of Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Electromyography; Female; Humans; Levodopa; Male; Mi | 1994 |
A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor.
Topics: Acetates; Administration, Oral; Aged; Amines; Antiparkinson Agents; Cross-Over Studies; Cyclohexanec | 1999 |
The effect of propranolol versus placebo on resident surgical performance.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Anxiety Agents; Anxiety; Cross-Over Studies; Double-Blind M | 1998 |
Effects of high ambient temperature on parasympathetically mediated cardiovascular reflexes in normal man.
Topics: Adult; Blood Pressure; Cardiovascular Physiological Phenomena; Double-Blind Method; Heart Rate; Huma | 2000 |
[Indications for beta-blockers in neurology].
Topics: Alcoholism; Antiparkinson Agents; Anxiety; Clinical Trials as Topic; Drug Therapy, Combination; Huma | 1978 |
Relationship between plasma propranolol levels and the clinical suppression of essential tremor [proceedings].
Topics: Humans; Propranolol; Tremor | 1979 |
beta-Adrenoreceptor antagonists in essential tremor.
Topics: Adult; Aged; Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Male; Middle Aged; Place | 1979 |
Comparison between the effects of pindolol and propranolol on essential tremor.
Topics: Adolescent; Adult; Drug Evaluation; Humans; Middle Aged; Pindolol; Propranolol; Tremor | 1977 |
Effect of propranolol on acute withdrawal tremor in alcoholic patients.
Topics: Acute Disease; Adult; Age Factors; Aged; Alcoholism; Clinical Trials as Topic; Drug Evaluation; Fema | 1976 |
[Treatment of benign essential tremor with propranolol].
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Middl | 1976 |
Long-term therapy of essential tremor with propranolol.
Topics: Adult; Age Factors; Aged; Clinical Trials as Topic; Diazepam; Female; Humans; Male; Middle Aged; Pla | 1976 |
The effects of propranolol, practolol, and placebo on the clinical manifestations of thyrotoxicosis.
Topics: Auscultation; Clinical Trials as Topic; Female; Heart Rate; Humans; Hyperthyroidism; Male; Practolol | 1976 |
The effect of d-propranolol on action tremors.
Topics: Clinical Trials as Topic; Humans; Propranolol; Tremor | 1976 |
Beta blockade in lithium tremor.
Topics: Affective Symptoms; Clinical Trials as Topic; Humans; Lithium; Practolol; Propranolol; Tremor | 1975 |
Effect of propranolol on essential tremor.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Propranolol; Tremor | 1976 |
Essential tremor: treatment with propranolol.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Propranolol; Tremor | 1975 |
Effect of propranolol in head tremor: quantitative study following single-dose and sustained drug administration.
Topics: Adult; Aged; Delayed-Action Preparations; Double-Blind Method; Female; Head; Humans; Male; Middle Ag | 1992 |
[Comparative study of theophylline and propranolol in essential tremor].
Topics: Aged; Drug Evaluation; Female; Hand; Humans; Male; Placebos; Propranolol; Theophylline; Tremor | 1992 |
The effect of theophylline on essential tremor: the possible role of GABA.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Animals; Cerebral Cortex; Delayed-Action Preparations; Do | 1991 |
Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cognition; Double-Blind Method; Female | 1990 |
A dose-ranging study to evaluate the beta-adrenoceptor selectivity of single doses of betaxolol.
Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Dose-Response Relationship, Drug; Heart Rate; Humans; | 1990 |
Propranolol, clonidine, urapidil and trazodone infusion in essential tremor: a double-blind crossover trial.
Topics: Adult; Aged; Aged, 80 and over; Clonidine; Double-Blind Method; Female; Humans; Injections, Intraven | 1989 |
Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man.
Topics: Adult; Atenolol; Blood Pressure; Drug Interactions; Fingers; Heart Rate; Hemodynamics; Humans; Isopr | 1988 |
Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Benzeneacetamides; Blood Glucose; Blood Pressure; Doub | 1986 |
Exercise-induced hand tremor: a possible test for beta 2-adrenoceptor selectivity in man?
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Hand; Heart Rate; Humans; Male; Physical Exertion; Pro | 1986 |
Selective adrenergic beta-2-receptor blocking drug, ICI-118.551, is effective in essential tremor.
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; M | 1986 |
Primidone and propranolol in essential tremor: a study based on quantitative tremor recording and plasma anticonvulsant levels.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Female; Heart Rate; Humans; Male; Middle A | 1987 |
Comparative studies on the effects of beta-adrenergic blockers in essential tremor.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Prop | 1987 |
The comparative effects of ICI 118551 and propranolol on essential tremor.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; H | 1987 |
Disability in essential tremor: effect of treatment.
Topics: Aged; Disabled Persons; Drug Therapy, Combination; Hand; Head; Humans; Male; Middle Aged; Motor Skil | 1986 |
Propranolol and propranolol-LA in essential tremor: a double blind comparative study.
Topics: Adolescent; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Dose | 1988 |
Pindolol-induced tremor.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Male; Pindolol; Propranol | 1987 |
Adrenergic beta 2-selective blocker in isoprenaline-enhanced essential tremor.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; I | 1987 |
Propranolol for the treatment of the alcoholic hangover.
Topics: Adult; Alcoholic Intoxication; Double-Blind Method; Female; Heart Rate; Humans; Male; Propranolol; R | 1986 |
A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Primidone; Propran | 1986 |
Adjuvant therapy of parkinsonian tremor.
Topics: Aged; Antiparkinson Agents; Carbidopa; Clonazepam; Double-Blind Method; Drug Therapy, Combination; H | 1987 |
Calcium channel blockers and essential tremor.
Topics: Adult; Blood Pressure; Female; Humans; Male; Middle Aged; Nifedipine; Propranolol; Tremor; Verapamil | 1987 |
Essential voice tremor: treatment with propranolol.
Topics: Aged; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Propranolol; Speech Disorders; Tr | 1985 |
Efficacy of primidone in essential tremor.
Topics: Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Phenobarbital; Primidone; Propranolol; | 1986 |
Propranolol in essential tremor.
Topics: Benzazepines; Clinical Trials as Topic; Humans; Male; Propranolol; Tremor; Urination Disorders | 1972 |
Treatment of essential tremor with propranolol.
Topics: Clinical Trials as Topic; Humans; Placebos; Propranolol; Tremor | 1973 |
Letter: Propranolol treatment of lithium-induced tremor.
Topics: Clinical Trials as Topic; Humans; Lithium; Propranolol; Tremor | 1973 |
Letter: Levodopa-propranolol therapy in parkinsonian tremor.
Topics: Blood-Brain Barrier; Dihydroxyphenylalanine; Drug Synergism; Drug Therapy, Combination; Humans; Neur | 1974 |
Letter: Propranolol in Parkinson's disease.
Topics: Dihydroxyphenylalanine; Drug Evaluation; Drug Therapy, Combination; Humans; Parkinson Disease; Place | 1974 |
[Clinical treatment of lithium induced tremors with a beta receptor antagonist (propranolol)].
Topics: Adjustment Disorders; Adrenergic beta-Antagonists; Bipolar Disorder; Chemical Phenomena; Chemistry; | 1971 |
Beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alcoholism; Amphetamine; Animals; Antidepressive Agents; | 1974 |
Effect of adrenergic beta-blockade on parkinsonian tremor.
Topics: Epinephrine; Ethanolamines; Humans; Parkinson Disease; Placebos; Propranolol; Tremor | 1965 |
Propranolol in the treatment of tremor.
Topics: Clinical Trials as Topic; Emotions; Humans; Parkinson Disease; Placebos; Propranolol; Tremor | 1972 |
Treatment of benign essential tremor with propranolol. A controlled clinical trial.
Topics: Adolescent; Adult; Age Factors; Aged; Clinical Trials as Topic; Female; Humans; Middle Aged; Placebo | 1973 |
Effect of the beta adrenergic blocking agent propranolol on essential tremor.
Topics: Adult; Aged; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Eval | 1973 |
Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties.
Topics: Activities of Daily Living; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Handwrit | 1974 |
A comparison of propranolol and benzhexol in essential tremor.
Topics: Aged; Clinical Trials as Topic; Diarrhea; Female; Handwriting; Humans; Male; Middle Aged; Nausea; Pr | 1974 |
[Letter: Propranolol treatment of lithium tremor].
Topics: Humans; Lithium; Placebos; Propranolol; Tremor | 1973 |
Propranolol treatment of essential tremor.
Topics: Adult; Aged; Ethanol; Evaluation Studies as Topic; Female; Heart Rate; Humans; Hypnotics and Sedativ | 1974 |
The control of essential tremor by propranolol.
Topics: Clinical Trials as Topic; Evaluation Studies as Topic; Humans; Placebos; Propranolol; Tremor | 1971 |
159 other studies available for propranolol and Tremor
| Article | Year |
|---|---|
Thalamo-cortical network is associated with harmaline-induced tremor in rodent model.
Topics: Animals; Deep Brain Stimulation; Essential Tremor; Harmaline; Motor Cortex; Propranolol; Rats; Roden | 2022 |
Prospective, longitudinal analysis of medication use in a cohort of elderly essential tremor cases.
Topics: Aged; Aged, 80 and over; Essential Tremor; Humans; Longitudinal Studies; Primidone; Propranolol; Tre | 2022 |
Mapping Pharmacologically Evoked Neurovascular Activation and Its Suppression in a Rat Model of Tremor Using Functional Ultrasound: A Feasibility Study.
Topics: Animals; Essential Tremor; Feasibility Studies; Harmaline; Propranolol; Rats; Tremor | 2023 |
Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice.
Topics: Animals; Brain; Cytochrome P-450 CYP2D6; Harmine; Humans; Hypothermia, Induced; Injections, Intraven | 2020 |
Shaking and tremors in thyroid storm.
Topics: Adult; Female; Graves Disease; Humans; Propranolol; Thyroid Crisis; Tremor | 2019 |
Serotonin syndrome unmasking thyrotoxicosis.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Aftercare; Anti-Arrhythmia Agents; Antithyroid Agents; Carbima | 2019 |
Secondary orthostatic tremor in the setting of cerebellar degeneration.
Topics: Adrenergic beta-Antagonists; Aged, 80 and over; Brain; Cognition; Gait Disorders, Neurologic; Humans | 2016 |
Reversible Cerebral Atrophy in Infantile Tremor Syndrome.
Topics: Atrophy; Brain; Brain Diseases; Female; Humans; Infant; Magnetic Resonance Imaging; Malnutrition; Pr | 2016 |
Infantile Tremor Syndrome.
Topics: Humans; Infant; Infant Nutrition Disorders; Male; Propranolol; Syndrome; Tremor; Vitamins | 2016 |
Pharmacological characterization of harmaline-induced tremor activity in mice.
Topics: Affect; Animals; Anticonvulsants; Baclofen; Behavior, Animal; Benzazepines; Carbolines; Chlordiazepo | 2009 |
Hypokalemic periodic paralysis due to Graves Disease.
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Anxiety; Arrhythmias, Cardiac; Dyspnea; Graves Di | 2009 |
[Postural tremor as first symptom of Huntington disease].
Topics: Adrenergic beta-Antagonists; Adult; Dopamine Antagonists; Dystonia; Family; Female; Humans; Huntingt | 2010 |
Pharmacologic management of essential tremor.
Topics: Adrenergic beta-Antagonists; Aged; Anticonvulsants; Ethanol; Humans; Male; Phenobarbital; Primidone; | 2010 |
Tremor in X-linked recessive spinal and bulbar muscular atrophy (Kennedy's disease).
Topics: Adrenergic beta-Antagonists; Adult; Age of Onset; Bulbo-Spinal Atrophy, X-Linked; Humans; Male; Midd | 2011 |
The effects of ion channel blockers validate the conductance-based model of saccadic oscillations.
Topics: Case-Control Studies; Ethosuximide; Humans; Ion Channels; Models, Biological; Models, Neurological; | 2011 |
Beta-adrenergic modulation of tremor and corticomuscular coherence in humans.
Topics: Adult; Albuterol; Female; Hand Strength; Humans; Male; Motor Cortex; Muscle, Skeletal; Propranolol; | 2012 |
Scurvy in infantile tremor syndrome.
Topics: Age Factors; Ascorbic Acid; Ascorbic Acid Deficiency; Folic Acid; Humans; Infant; Iron; Male; Malnut | 2005 |
Propranolol--an aid to microvascular surgery.
Topics: Adrenergic beta-Antagonists; General Surgery; Humans; Microsurgery; Motor Skills; Propranolol; Tremo | 2008 |
Evidence for a direct peripheral effect of adrenaline on physiological tremor in man.
Topics: Epinephrine; Fingers; Forearm; Humans; Isoproterenol; Peripheral Nerves; Phenoxybenzamine; Propranol | 1967 |
Nature of the tremors induced by p-methoxydopamine.
Topics: Animals; Chlorpromazine; Dopamine; Male; Methylation; Mice; Movement; Parasympatholytics; Phenobarbi | 1967 |
Mechanisms underlying emotional variation in parkinsonian tremor.
Topics: Drug Antagonism; Epinephrine; Humans; Hypoglycemia; Insulin; Movement; Parkinson Disease; Problem So | 1967 |
Metoprolol in essential tremor.
Topics: Dose-Response Relationship, Drug; Humans; Isoproterenol; Metoprolol; Propanolamines; Propranolol; Tr | 1980 |
Beta adrenergic blockers in tremor.
Topics: Adrenergic beta-Antagonists; Anxiety; Humans; Oxprenolol; Parkinson Disease; Propranolol; Tremor | 1981 |
[Therapy of essential tremor with special reference to the use of beta-blockers].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bupranolol; Double-Blind Method; Female; Humans; | 1982 |
Case report of propranolol (Inderal) pharmacotherapy for neuroleptic-induced akathisia and tremor.
Topics: Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Ind | 1983 |
Beta-blockers in isoproterenol-enhanced essential tremor.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Humans; Isoproterenol; Metoprolol; Middle Aged; Propra | 1984 |
Enhancement of physiological finger tremor by intravenous isoprenaline infusions in man: evaluation of its role in the assessment of beta-adrenoceptor antagonists.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Dose-Response Relationship | 1984 |
[Essential tremor].
Topics: Humans; Propranolol; Tremor | 1982 |
An assessment of physiological finger tremor as an indicator of beta-adrenoceptor function.
Topics: Adult; Female; Fingers; Heart Rate; Humans; Isoproterenol; Male; Practolol; Propranolol; Receptors, | 1983 |
Tremor.
Topics: Humans; Primidone; Propranolol; Tremor | 1984 |
Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Individuality; Male; Midd | 1984 |
Propranolol therapy in a patient with panic disorder, tardive dyskinesia, and essential tremor.
Topics: Adult; Anxiety Disorders; Dyskinesia, Drug-Induced; Fear; Humans; Male; Panic; Propranolol; Tremor | 1984 |
Comparison of metoprolol and propranolol in the treatment of lithium tremor.
Topics: Humans; Lithium; Metoprolol; Propranolol; Tremor | 1984 |
Essential tremor: a risk factor for alcoholism?
Topics: Alcohol Drinking; Alcoholism; Humans; Male; Middle Aged; Propranolol; Risk; Tremor | 1984 |
Hypersensitivity to the tremorogenic action of nicotine in rats withdrawn from ethanol.
Topics: Animals; Ethanol; Humans; Male; Nicotine; Propranolol; Rats; Rats, Inbred Strains; Substance Withdra | 1983 |
Metoprolol compared with propranolol in the treatment of essential tremor.
Topics: Adult; Aged; Female; Humans; Male; Metoprolol; Middle Aged; Propranolol; Tremor | 1984 |
Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management.
Topics: Adolescent; Adult; Azathioprine; Chronic Disease; Dysgammaglobulinemia; Humans; Hypergammaglobulinem | 1984 |
Tremor due to sodium valproate.
Topics: Humans; Propranolol; Tremor; Valproic Acid | 1981 |
Benign familial tremor treated with primidone.
Topics: Adolescent; Adult; Aged; Humans; Male; Middle Aged; Phenobarbital; Phenylethylmalonamide; Primidone; | 1981 |
Concurrent use of antidepressants and propranolol: case report and theoretical considerations.
Topics: Anthracenes; Depressive Disorder; Drug Therapy, Combination; Humans; Male; Maprotiline; Middle Aged; | 1983 |
Imipramine-induced tremor: effects of a beta-adrenergic blocking agent.
Topics: Depressive Disorder; Humans; Imipramine; Male; Middle Aged; Propranolol; Tremor | 1983 |
Tics and tremors.
Topics: Adolescent; Child; Child, Preschool; Ethnicity; Female; Haloperidol; Humans; Male; Propranolol; Tic | 1982 |
Benign essential tremor: features that aid in diagnosis.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Child; Diagnosis, Differential; Female; Head; Humans; Mal | 1982 |
Plasma propranolol in essential tremor.
Topics: Dose-Response Relationship, Drug; Humans; Propranolol; Tremor | 1982 |
Propranolol, psychoneuroendocrine changes, and depression.
Topics: Aged; Depressive Disorder; Dexamethasone; Female; Humans; Hydrocortisone; Lithium; Propranolol; Trem | 1982 |
Effect of age, clonidine or propranolol on behavioral toxicity induced with digitoxin in mice.
Topics: Aging; Animals; Behavior, Animal; Clonidine; Digitoxin; Drug Interactions; Gait; Male; Mice; Postura | 1982 |
Atenolol vs. propranolol in essential tremor. A controlled, quantitative study.
Topics: Adult; Aged; Atenolol; Double-Blind Method; Female; Humans; Male; Middle Aged; Propanolamines; Propr | 1982 |
Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Propranolol; Tremor | 1981 |
Peripheral catecholamines mediate certain responses to central cholinergic receptor stimulation by oxotremorine.
Topics: Adrenal Medulla; Animals; Blood Pressure; Catecholamines; Epinephrine; Hydroxydopamines; Male; Norep | 1980 |
[The treatment of essential tremor with propranolol].
Topics: Humans; Propranolol; Tremor | 1981 |
Linoleic acid in the treatment of lithium toxicity and familial tremor.
Topics: Animals; Humans; Linoleic Acids; Lithium; Propranolol; Prostaglandins E; Purkinje Cells; Rats; Tremo | 1980 |
Linoleic acid in the treatment of lithium-induced tremor: a pilot trial with negative outcome.
Topics: Humans; Linoleic Acids; Lithium; Propranolol; Tremor | 1980 |
Propranolol treatment of albuterol poisoning in two asthmatic patients.
Topics: Adolescent; Albuterol; Asthma; Charcoal; Drug Overdose; Female; Gastric Lavage; Humans; Hypokalemia; | 1993 |
[Treatment of essential tremor].
Topics: Anti-Anxiety Agents; Anti-Dyskinesia Agents; Botulinum Toxins; Humans; Hypnotics and Sedatives; Meth | 1995 |
Primary writing tremor.
Topics: Adult; Aged; Disabled Persons; Ethanol; Female; H-Reflex; Handwriting; Humans; Male; Median Nerve; M | 1995 |
Inclusion body myositis associated with a severe unilateral levodopa-responsive upper extremity tremor.
Topics: Action Potentials; Anti-Dyskinesia Agents; Brain Neoplasms; Electromyography; Hand; Humans; Inclusio | 1996 |
Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats.
Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Animals; Carteolol; Dimethylphenylpiperazinium Iodid | 1997 |
Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage.
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Antiparkinson Agents; Cerebral Hemorrhage; Clonazepam; | 1997 |
[Assessment of anti-tremorogenic drugs--nicotine-induced tail-tremor model].
Topics: Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Clonazepam; Diazepam; Disease Models, Ani | 1997 |
Postural tremor after thalamic infarction.
Topics: Adrenergic beta-Antagonists; Aged; Anticonvulsants; Arm; Cerebral Infarction; Female; Humans; Primid | 1999 |
[Primary orthostatic tremor: report of 4 cases].
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Arm; Clonazepam; Depression; Diagnosis, Differential; E | 2000 |
Quantification of sensory trick impact on tremor amplitude and frequency in 60 patients with head tremor.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Anticonvulsants; Central Nervous System | 2000 |
The management of tremor.
Topics: Botulinum Toxins, Type A; Brain; Cholinergic Antagonists; Clonazepam; Diagnosis, Differential; Elect | 2002 |
[Lithium tremor-combination treatment with beta receptor blockaders].
Topics: Adrenergic beta-Antagonists; Humans; Lithium; Propranolol; Tremor | 1975 |
Physiological and pharmacological aids in the differential diagnosis of tremor.
Topics: Ataxia; Diagnosis, Differential; Ethanol; Humans; Isoproterenol; Levodopa; Methods; Parkinson Diseas | 1976 |
[Beta blockaders and general pathology].
Topics: Acebutolol; Adrenergic beta-Antagonists; Asthma; Female; Humans; Hypercalcemia; Hyperglycemia; Hypog | 1977 |
Acute brain syndrome after propranolol treatment.
Topics: Acute Disease; Aged; Female; Humans; Propranolol; Psychoses, Substance-Induced; Syndrome; Tremor | 1977 |
Beta-blockers in essential tremor.
Topics: Ethanol; Humans; Muscles; Propranolol; Receptors, Adrenergic, beta; Tremor | 1979 |
Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors.
Topics: Blood Pressure; Heart Rate; Humans; Informed Consent; Metoprolol; Propranolol; Receptors, Adrenergic | 1977 |
Suppression of essential tremor by propranolol: correlation of effect with intensity of beta-adrenergic blockade.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Humans; Middle Aged; Propranolol; Receptors, Adrenerg | 1976 |
Suppression of essential tremor by propranolol: correlation of effect with drug plasma levels and intensity of beta-adrenergic blockade.
Topics: Aged; Drug Evaluation; Humans; Middle Aged; Propranolol; Receptors, Adrenergic; Receptors, Adrenergi | 1977 |
New approaches in the management of hyperkinetic movement disorders.
Topics: 5-Hydroxytryptophan; Carbidopa; Chorea; Dyskinesia, Drug-Induced; Humans; Movement Disorders; Myoclo | 1977 |
The nature and etiology of normal and alcohol withdrawal tremor.
Topics: Alcoholism; Biomechanical Phenomena; Electromyography; Female; Humans; Male; Posture; Propranolol; S | 1979 |
Treatment of essential tremor with metoprolol.
Topics: Aged; Humans; Male; Metoprolol; Premedication; Propanolamines; Propranolol; Tremor | 1979 |
Relationship between plasma propranolol concentration and relief of essential tremor.
Topics: Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Pr | 1979 |
Modification by levo-propranolol of tremors induced by harmine in mice.
Topics: Animals; Cyproheptadine; Dose-Response Relationship, Drug; Harmine; Male; Mice; Phenoxybenzamine; Pr | 1979 |
Central cholinergic mechanisms in electrical self-stimulation and in drug-induced tremor in rats.
Topics: Animals; Apomorphine; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Hyp | 1979 |
Prevention of ethanol withdrawal seizures in mice by local anesthetics and dextro-propranolol.
Topics: Anesthetics, Local; Animals; Ataxia; Behavior, Animal; Ethanol; Female; Humans; Mice; Mice, Inbred C | 1977 |
Propranolol for severe post-head injury action tremor.
Topics: Brain Injuries; Child; Humans; Male; Movement; Propranolol; Tremor | 1978 |
The present status of propranolol.
Topics: Adrenal Gland Neoplasms; Angina Pectoris; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 1979 |
Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal.
Topics: Adult; Alcoholism; Catecholamines; Chlordiazepoxide; Dose-Response Relationship, Drug; Drug Evaluati | 1977 |
The shaking patient. Diagnosis and management of tremor.
Topics: Amantadine; Carbidopa; Cerebellar Diseases; Humans; Levodopa; Parkinson Disease; Propranolol; Tremor | 1977 |
[Neurologic indication for propranolol: essential tremor].
Topics: Adolescent; Adult; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Parkinson Disease; Pr | 1976 |
Modification of oxotremorine tremor and hypothermia by injections of drugs into the cerebral ventricles of the mouse.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Body Temperature; Dopamine; Drug Interactions; Female | 1976 |
Auyana head nodders: essential heredo-familial tremor in the Eastern Highlands.
Topics: Age Factors; Aged; Ethanol; Female; Humans; Male; Middle Aged; New Guinea; Pedigree; Propranolol; Se | 1975 |
A novel tremorigen antagonized by D-amphetamine.
Topics: Acetates; Aldehydes; Amines; Animals; Atropine; Calcium; Chlorpromazine; Dextroamphetamine; Diazepam | 1975 |
Letter: Lithium-induced tremor.
Topics: Aged; Female; Humans; Lithium; Propranolol; Tremor | 1975 |
Relative efficacy of alcohol and propranolol in action tremor.
Topics: Adult; Ataxia Telangiectasia; Cerebellar Diseases; Drug Evaluation; Ethanol; Female; Humans; Male; P | 1975 |
Essential (hereditary or senile) tremor.
Topics: Adolescent; Adult; Age Factors; Aged; Arm; Female; Head; Humans; Leg; Male; Middle Aged; Neck; Propr | 1975 |
Beta-adrenergic mechanisms in action tremor.
Topics: Administration, Oral; Arm; Brachial Artery; Depression, Chemical; Electromyography; Humans; Infusion | 1975 |
Editorial: Non-beta-blocking actions of propranolol.
Topics: Brain; Cardiac Output; Depression, Chemical; Humans; Hypertension; Propranolol; Receptors, Adrenergi | 1975 |
[Slow leg tremor].
Topics: Adult; Aged; Alcoholism; Follow-Up Studies; Humans; Leg; Levodopa; Male; Middle Aged; Propranolol; T | 1975 |
Essential tremor: a common and treatable disorder.
Topics: Diagnosis, Differential; Ethanol; Humans; Parkinson Disease; Propranolol; Tremor | 1976 |
Antioxotremorine action of propranolol.
Topics: Animals; Blood Pressure; Diaphragm; Guinea Pigs; In Vitro Techniques; Male; Mice; Muscle Contraction | 1976 |
Letter: Effect of propranolol on tremor of alcohol withdrawal.
Topics: Alcoholism; Humans; Propranolol; Substance Withdrawal Syndrome; Tremor | 1976 |
Control of lithium tremor with propranolol.
Topics: Adult; Bipolar Disorder; Female; Humans; Lithium; Propranolol; Tremor | 1976 |
Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic beta-Antagonists; Animals; Macaca fascicula | 1992 |
Orthostatic tremor associated with voice tremor.
Topics: Aged; Electromyography; Female; Humans; Muscles; Neurologic Examination; Posture; Propranolol; Tremo | 1992 |
A new drug for treatment of essential tremor? Time will tell.
Topics: Humans; Methazolamide; Primidone; Propranolol; Tremor | 1991 |
Treatment of essential tremor with methazolamide.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arm; Female; Head; Humans; Leg; Male; Methazolamide; Mi | 1991 |
Essential tremor: clinical correlates in 350 patients.
Topics: Adult; Aged; Aging; Alcohol Drinking; Female; Humans; Male; Middle Aged; Movement Disorders; Primido | 1991 |
Essential tremor: clinical, electromyographical and pharmacological studies in 146 Chinese patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Electromyography; Female; Humans; Male; Middle Aged; Pos | 1990 |
[Tremor. Possibilities and limits of drug therapy].
Topics: Humans; Parasympatholytics; Parkinson Disease; Primidone; Propranolol; Tremor | 1990 |
Clinical and computer-based assessment of long-term therapeutic efficacy of propranolol in essential tremor.
Topics: Aged; Dose-Response Relationship, Drug; Electronic Data Processing; Female; Humans; Male; Middle Age | 1990 |
Acute and chronic effects of propranolol and primidone in essential tremor.
Topics: Aged; Drug Evaluation; Female; Humans; Male; Primidone; Propranolol; Time Factors; Tremor | 1989 |
Cholinergic involvement in the modulation of oxotremorine-tremor in mice by propranolol.
Topics: Adrenergic beta-Antagonists; Animals; Atropine; Brain; Cholinesterase Inhibitors; Dose-Response Rela | 1985 |
Ethanol withdrawal tremor potentiates the tremorogenic action of nicotine.
Topics: Animals; Ethanol; Hexamethonium; Hexamethonium Compounds; Male; Nicotine; Propranolol; Rats; Rats, I | 1985 |
Blockade of central beta-adrenoceptors attenuates tremor induced by 5-hydroxytryptamine (5-HT)-receptor activation in rats.
Topics: 5-Hydroxytryptophan; Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Male; M | 1987 |
Post-traumatic tremor.
Topics: Adult; Clonazepam; Consciousness; Craniocerebral Trauma; Electromyography; Female; Humans; Male; Mid | 1989 |
Psychoses associated with propranolol withdrawal.
Topics: Aged; Delusions; Female; Humans; Middle Aged; Paranoid Disorders; Propranolol; Psychoses, Substance- | 1989 |
[Power spectral analysis of tremor induced by TRH and oxotremorine in mice].
Topics: Animals; Atropine; Haloperidol; Male; Mice; Oxotremorine; Propranolol; Reaction Time; Thyrotropin-Re | 1986 |
Hereditary essential tremor in Buenos Aires (Argentina).
Topics: Argentina; Diagnosis, Differential; Female; Gene Pool; Humans; Male; Pedigree; Primidone; Propranolo | 1988 |
Essential tremor variants: effect of treatment.
Topics: Adult; Aged; Clonazepam; Female; Humans; Male; Middle Aged; Primidone; Propranolol; Tremor | 1987 |
Essential tongue tremor.
Topics: Adolescent; Adult; Aged; Clonazepam; Coxsackievirus Infections; Electroencephalography; Ethanol; Fem | 1987 |
[Essential tremor: therapeutic possibilities].
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Primidone; Propranolol; Tremor | 1987 |
Modulation of p,p'-DDT-induced tremor by catecholaminergic agents.
Topics: Animals; Apomorphine; Clonidine; DDT; Dopamine; Haloperidol; Male; Norepinephrine; Phenoxybenzamine; | 1987 |
Time course of a single oral dose of propranolol in essential tremor.
Topics: Humans; Propranolol; Tremor | 1986 |
Essential tremor.
Topics: Diagnosis, Differential; Humans; Parkinson Disease; Phenobarbital; Phenylethylmalonamide; Primidone; | 1986 |
The effect of propranolol on whole-body microvibrations during examination stress.
Topics: Adult; Cardiac Output; Female; Humans; Male; Mathematics; Propranolol; Sex Factors; Stress, Physiolo | 1986 |
Kinetic predominant essential tremor: successful treatment with clonazepam.
Topics: Aged; Aged, 80 and over; Clonazepam; Electromyography; Ethanol; Female; Handwriting; Humans; Male; M | 1987 |
Generalized pustular psoriasis provoked by propranolol.
Topics: Aged; Humans; Male; Methotrexate; Propranolol; Psoriasis; Skin Diseases, Vesiculobullous; Tremor | 1985 |
Dose-response relationship of propranolol in the treatment of essential tremor.
Topics: Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Propranolol; Tremor | 1986 |
Long-acting propranolol in essential tremor.
Topics: Humans; Male; Middle Aged; Propranolol; Tremor | 1985 |
Propranolol in essential tremor.
Topics: Humans; Propranolol; Tremor | 1985 |
Writing tremor: its relationship to benign essential tremor.
Topics: Adult; Aged; Electromyography; Ethanol; Female; Handwriting; Humans; Male; Middle Aged; Muscles; Pro | 1985 |
Combined resting-postural tremors.
Topics: Aged; Ethanol; Female; Humans; Levodopa; Male; Middle Aged; Posture; Propranolol; Rest; Tremor; Trih | 1985 |
Time course of a single oral dose of propranolol in essential tremor.
Topics: Aged; Humans; Male; Middle Aged; Propranolol; Tremor | 1985 |
Treatment of essential tremor--further comment.
Topics: Humans; Primidone; Propranolol; Tremor | 1985 |
Propranolol and lithium-induced tremor.
Topics: Humans; Lithium; Propranolol; Tremor | 1972 |
Propranolol in essential tremor.
Topics: Humans; Propranolol; Tremor | 1972 |
Propranolol in essential tremor.
Topics: Humans; Propranolol; Tremor | 1973 |
Beta-adrenergic blockers in benign essential tremor.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Alcoholic Beverages; Ethanol; Female; Huma | 1973 |
Drug treatment of diseases characterized by abnormal movements.
Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; My | 1973 |
The effect of adrenaline on the contraction of human muscle--one mechanism whereby adrenaline increases the amplitude of physiological tremor.
Topics: Animals; Cats; Epinephrine; Hindlimb; Humans; Infusions, Parenteral; Isoproterenol; Leg; Motor Neuro | 1968 |
Antagonism of intracaudate carbachol tremor by local injections of catecholamines.
Topics: Adenosine Triphosphate; Animals; Brain; Carbachol; Cats; Chlorpromazine; Dopamine; Electrophysiology | 1967 |
[Inhibition of tremor by active beta-adrenolytic substances].
Topics: Animals; Depression, Chemical; Isoproterenol; Mice; Parkinson Disease; Propranolol; Sensory Receptor | 1967 |
Motor disturbance induced by tremorine and oxotremorine.
Topics: Acetylcholine; Amines; Animals; Atropine; Biperiden; Brain; Bridged-Ring Compounds; Chlorpromazine; | 1970 |
Mechanism of antitremorine-activity of adrenergic beta-receptor antagonists in the rat.
Topics: Adrenergic beta-Antagonists; Amino Alcohols; Injections, Intraperitoneal; Phenethylamines; Propranol | 1970 |
Effect of L-dopa, adrenergic -blockers and anticholinergic agents on the tremorine-tremor in mice.
Topics: Adrenergic beta-Antagonists; Amino Alcohols; Animals; Dihydroxyphenylalanine; Drug Combinations; Hyd | 1971 |
The effects of some beta adrenergic blocking agents on the central and peripheral actions of tremorine and oxotremorine.
Topics: Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Animals; Atropine; Central Nervous System; | 1972 |
Beta-adrenergic mechanisms in essential tremor.
Topics: Administration, Oral; Electromyography; Humans; Injections, Intra-Arterial; Isoproterenol; Propranol | 1974 |
Hand tremor induced by industrial exposure to inorganic mercury.
Topics: Environmental Exposure; Female; Fingers; Hand; Humans; Mercury; Mercury Poisoning; Occupational Dise | 1973 |
[Treatment of essential familial tremor with propanolol].
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Nausea; Propranolol; Tachycardia; Tremor; Vomiting | 1973 |
Inderal (propranolol) in the treatment of alcoholism.
Topics: Adult; Alcoholism; Anxiety; Humans; Propranolol; Substance Withdrawal Syndrome; Tremor | 1973 |
Neuro pharmacological studies on propranolol--a beta adrenergic blocking agent.
Topics: Analgesics; Animals; Columbidae; Motor Activity; Pentobarbital; Propranolol; Rats; Seizures; Sleep; | 1973 |
[Clinical use of propranolol].
Topics: Alcoholism; Angina Pectoris; Aortic Aneurysm; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flut | 1974 |
An investigation of the tremorgenic actions of harmine in the rat.
Topics: Acetylcholine; Alkaloids; Animals; Atropine; Brain Chemistry; Carbamates; Guinea Pigs; In Vitro Tech | 1971 |
Alterations in tremor regulation after intracaudate injections of calcium ions or disodium edetate.
Topics: Animals; Calcium; Carbachol; Cats; Caudate Nucleus; Dopamine; Edetic Acid; Magnesium; Membrane Poten | 1971 |
Use of cumulative dose-response curves in potency comparisons of sympathomimetic amines on the cat soleus muscle.
Topics: Animals; Cats; Epinephrine; Isoproterenol; Methods; Muscle Contraction; Muscles; Propranolol; Quinol | 1972 |
Treatment of essential tremor with propranolol.
Topics: Humans; Parkinson Disease; Propranolol; Tremor | 1972 |
The effect of adrenergic beta-receptor blocking drugs on tremor.
Topics: Aged; Dopamine; Female; Humans; Male; Parkinson Disease; Propranolol; Sensory Receptor Cells; Sympat | 1971 |
Non-resting tremor in Parkinson's disease.
Topics: Aged; Amantadine; Dihydroxyphenylalanine; Humans; Male; Parkinson Disease; Propranolol; Tremor | 1971 |
Anti-tremor action of propranolol (Inderal).
Topics: Animals; Atropine; Diarrhea; Female; Male; Propranolol; Rats; Salivary Glands; Tremor; Tremorine | 1967 |
Effects of drugs on tremor and increase in brain acetylcholine produced by oxotremorine in the rat.
Topics: Acetylcholine; Animals; Brain; Brain Chemistry; Male; Phenoxybenzamine; Phenylalanine; Propranolol; | 1970 |
Effect of beta-adrenergic blockade on finger tremor and Achilles reflex time in anxious and thyrotoxic patients.
Topics: Achilles Tendon; Adult; Aged; Anxiety; Epinephrine; Female; Fingers; Humans; Hyperthyroidism; Male; | 1968 |
[Kr 339, a new tremor-inhibiting preparation for the therapy of Parkinson's syndrome].
Topics: Adult; Aged; Chemical Phenomena; Chemistry; Drug Synergism; Female; Humans; Male; Middle Aged; Muscl | 1968 |
[On the effect of beta-adrenolytic substances on experimental static tremor].
Topics: Animals; Mice; Oxidation-Reduction; Propranolol; Sympatholytics; Tremor; Tremorine | 1969 |
The role of the ballistocardiac impulse in the genesis of physiological tremor.
Topics: Arm; Ballistocardiography; Cardiac Output; Epinephrine; Fingers; Heart; Heart Rate; Humans; Ischemia | 1969 |
Measurement of rigidity and tremor in Parkinson's disease.
Topics: Elasticity; Humans; Joint Diseases; Joints; Movement; Orphenadrine; Oscillometry; Parasympatholytics | 1969 |